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If, then, there is some end of the things we do, which we desire for its own sake
(everything else being desired for the sake of this), and if we do not choose everything
for the sake of something else (for at that rate the process would go on to infinity, so
that our desire would be empty and vain), clearly this must be the good and the chief
good. Will not the knowledge of it, then, have a great influence on life? Shall we not,
like archers who have a mark to aim at, be more likely to hit upon what is right? If so,
we must try, in outline at least, to determine what it is, and of which of the sciences or
capacities it is the object.
Aristotle, Nikomachean Ethics. Translation W.D.Ross
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Abstract
Quality of life (QoL) is becoming one of the key outcomes of health care. This is due to
increased respect for the subjective valuations and well-being of patients and an
increasing part of the ageing population living with chronic, non-fatal conditions.
Health-related quality of life (HRQoL) aims to capture the aspects of QoL that health and
health care can influence. Preference-based generic HRQoL measures enable estimation of
health utility, the quality component needed for calculating quality-adjusted life years
(QALYs). These combine morbidity and mortality into a single index, allowing direct
comparisons across different treatments and conditions, and can thus be very useful for
rational rationing, evidence-based medicine and other health policy decisions.
Ideally, the HRQoL associated with different conditions is estimated using a
representative general population sample, reliable diagnostics and preference-based HRQoL
measures. However, studies like this are lacking, as mental disorders can not be reliably
diagnosed utilizing simple self-report measures used in most surveys. HRQoL studies using
proxy-measures for mental disorders, and studies using other methods for estimating the
burden of disease, have suggested that mental disorders may be comparable in severity to
the most serious somatic conditions, and that they may be the single largest cause of
non-fatal disease burden in the developed world.
This study aimed to compare the individual severity (in decreased HRQoL) and public health
burden (in QALYs lost to morbidity) of major chronic conditions in Finland, including and
focusing on reliably diagnosed psychiatric conditions. The relationship between HRQoL and
different age-groups, different classes of anxiety and depressive disorders and different
alcohol consumption patterns was investigated separately.
The study is based on the Health 2000 survey, a representative general population survey
of 8028 Finns aged 30 and over. Sociodemographic information, alcohol consumption and
self-reported somatic conditions (if diagnosed by a physician) were asked for with
interviews. Depressive, anxiety and alcohol use disorders were diagnosed with the
Composite International Diagnostic Interview (M-CIDI). HRQoL was measured with two
preference-based questionnaire measures, the 15D and the EQ-5D, with 83% of the sample
completing at least one of the instruments.
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This study found that people with psychiatric disorders had the lowest 15D HRQoL scores at
all ages, in comparison to other main groups of chronic conditions. Considering 29
individual conditions, three of the four most severe (on 15D) were psychiatric disorders;
the most severe was Parkinson’s disease. Of the psychiatric disorders, chronic conditions
that have sometimes been considered relatively mild - dysthymia, agoraphobia, generalized
anxiety disorder and social phobia - were found to be the most severe, as measured with
HRQoL. This was explained both by the severity of the impact of these disorders on mental
health domains of HRQoL, and also by the fact that decreases were widespread on most
dimensions of HRQoL.
Considering the public health burden of conditions, musculoskeletal disorders were
associated with the largest burden, followed by psychiatric disorders. These were
associated with 23% and 12% of the total QALYs lost due to morbidity on 15D, respectively,
as identified in this study. Psychiatric disorders were associated with the largest burden
at younger ages, accounting for 37% of the disease burden at ages 30-45 years. Of
individual conditions, the largest burden found was for depressive disorders, followed by
urinary incontinence and arthrosis of the hip and knee. The public health burden increased
greatly with age, so the ageing of the Finnish population will mean that the disease
burden caused by chronic conditions will increase by a quarter up to year 2040, if
morbidity patterns do not change.
Investigating alcohol consumption and HRQoL revealed that although abstainers had poorer
HRQoL than moderate drinkers, this was mainly due to many abstainers being former drinkers
and having the poorest HRQoL. Moderate drinkers did not have significantly better HRQoL
than abstainers who were not former drinkers. Also heavy drinkers had lower HRQoL than
abstainers who were not former drinkers, but this was statistically significant only for
the most heavily drinking 5-10% (women drinking on average 24 drinks and men 52 drinks per
week).
In conclusion, this study showed that psychiatric disorders are associated with a large
part of the non-fatal disease burden in Finland. In particular anxiety disorders appear to
be more severe and have a larger public health burden than previously thought. More
generally, this study showed that measuring HRQoL at population level can be feasible and
it can provide important and useful information regarding the well-being of the
population.
Keywords: Mental disorders, health-related quality of life, quality of life, 15D, EQ-5D,
Finland, survey
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Tiivistelmä
Elämänlaadun merkitys terveydenhuollon päämääränä on korostumassa. Tämä johtuu potilai-
den omien arvostusten painoarvon kasvusta sekä väestön ikääntymisestä seuraavasta
kroonisten sairauksien suhteellisesta yleistymisestä. "Terveyteen liittyvä elämänlaatu"
pyrkii tavoittamaan ne elämänlaadun osat, joihin terveys ja terveydenhuolto voivat
vaikuttaa. Preferenssipohjaisten, taudeista riippumattomien terveyteen liittyvän
elämänlaadun mittareiden käyttö mahdollistaa ns. terveysutiliteettien arvioinnin; nämä
muodostavat laatupainotteisten elinvuosien (Quality-adjusted life years, QALY)
laatutekijän. Laatupainotteiset elinvuodet yhdistävät sairastavuuden ja kuolleisuuden
yhdeksi summapistemääräksi, mikä mahdollistaa erilaisten hoitojen ja sairauksien
vaikutusten suoran vertailun. Tämä voi hyödyttää terveydenhuollon resurssien rationaalista
jakoa, näyttöön perustuvaa lääketiedettä ja muuta terveyspoliittista päätöksentekoa.
Eri tautien elämänlaatuvaikutusten mittaus edellyttää kattavan väestöaineiston sekä
luotettavan diagnostiikan. Tämänkaltaisia, preferenssipohjaisia terveyteen liittyvän
elämänlaadun mittareita käyttäviä tutkimuksia ei kuitenkaan juuri ole. Mielenterveyden
häiriöitä ei voi luotettavasti diagnosoida yksinkertaisilla kyselyillä, joita useimmissa
väestötutkimuksissa käytetään. Olemassa olevat mielenterveyttä sivuavat, terveyteen
liittyvää elämänlaatua tai muita väestön tautikuormaa mittaavia menetelmiä käyttävät
tutkimukset kuitenkin viittaavat siihen, että mielenterveyden häiriöt voivat olla yhtä
vakavia kuin vakavimmat yleiset somaattiset sairaudet, ja ne voivat olla suurin
yksittäinen tautitaakkaa aiheuttava sairausryhmä länsimaissa.
Tämän tutkimuksen tavoitteena oli vertailla keskeisten kroonisten sairauksien vaikutusta
sekä yksilöiden terveyteen liittyvään elämänlaatuun että kansanterveyteen arvioimalla
sairastamiseen liittyviä laatupainotteisten elinvuosien menetyksiä. Tutkimus keskittyy
erityisesti mielenterveyden häiriöihin. Iän, eri ahdistuneisuus- ja masennushäiriöiden
sekä alkoholinkäytön yhteys terveyteen liittyvään elämänlaatuun tutkittiin erikseen.
Tutkimus pohjautuu Terveys 2000 - tutkimukseen, joka on kattava väestöotos sisältäen 8028
vähintään 30-vuotiasta suomalaisista. Sosiodemografiset perustiedot, alkoholinkäyttötavat
ja lääkärin toteamat somaattiset sairaudet selvitettiin haastattelulla. Masennus-,
ahdistus- ja alkoholihäiriöt diagnosoitiin strukturoidulla mielenterveyshaastattelulla
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(M-CIDI). Terveyteen liittyvää elämänlaatua mitattiin 15D ja EQ-5D kyselyillä, joista
jompaankumpaan 83% vastasi hyväksyttävästi.
Tutkimuksessa todettiin, että mielenterveyden häiriöistä kärsivillä on matalin terveyteen
liittyvä elämänlaatu (15D) kaikissa ikäluokissa, muihin sairausryhmiin verrattuna.
Tutkittaessa 29 sairautta erikseen 15D:llä, vakavimmaksi yksilötasolla osoittautui
Parkinsonin tauti, mutta seuraavat kolme olivat mielenterveyden häiriöitä. Tutkittaessa
mielenterveyden häiriöitä tarkemmin, vakavimmiksi osoittautuivat pitkäaikainen masennus
(dystymia), julkisten paikkojen pelko (agorafobia), yleistynyt ahdistuneisuushäiriö ja
sosiaalisten tilanteiden pelko. Tämä johtui toisaalta useilla terveyteen liittyvän
elämänlaadun osa-alueilla todetusta heikentymisestä, toisaalta mielenterveyteen liittyvien
osa-alueiden heikentymisen voimakkuudesta.
Tutkittaessa häiriöiden vaikutuksia kansanterveyteen sairastamiseen liittyvien
laatupainotteisten elinvuosien menetyksinä, tuki- ja liikuntaelinsairaudet sekä
mielenterveyden häiriöt aiheuttivat suurimman sairauskuorman. Ensin mainittuihin liittyi
23% ja jälkimmäisiin 12% tässä tutkimuksessa 15D:llä todetuista laatupainotteisten
elinvuosien menetyksistä. Mielenterveyden häiriöihin liittyi kuitenkin 37% tautitaakasta
nuorimmassa, 30-45 vuotiaiden ikäryhmässä. Yksittäisistä sairauksista suurimman
tautikuorman aiheuttivat masennus, virtsainkontinenssi ja polven tai lonkan nivelrikko.
Koska sairastavuus lisääntyi jyrkästi iän myötä, koko väestön ikääntyminen lisää
kroonisten sairauksien aiheuttamaa tautikuormaa noin neljänneksellä vuoteen 2040 mennessä,
mikäli sairastavuus pysyy nykyisellään.
Tutkittaessa alkoholinkäyttöä ja terveyteen liittyvää elämänlaatua todettiin, että
absolutisteilla oli huonompi terveyteen liittyvä elämänlaatu kuin kohtuukäyttäjillä. Tämä
johtui kuitenkin pääosin siitä, että merkittävä osa absolutisteista oli entisiä
alkoholinkäyttäjiä, joiden terveyteen liittyvä elämänlaatu oli erityisen huono. Verrattuna
absolutisteihin, jotka eivät olleet entisiä alkoholinkäyttäjiä, kohtuukäyttäjien
terveyteen liittyvä elämänlaatu oli yhtä hyvä, mutta eniten alkoholia käyttävän 5-10%:n
selkeästi huonompi. Selkein terveyteen liittyvän elämänlaadun lasku koski naisia, jotka
juovat yli 24 annosta ja miehiä, jotka juovat yli 52 annosta alkoholia viikossa.
Yhteenvetona tutkimus osoitti, että suuri osa kroonisiin sairauksiin yhdistettävästä
terveyteen liittyvän elämänlaadun menetyksestä liittyy mielenterveyden häiriöihin.
Erityisesti ahdistuneisuushäiriöiden vaikutukset osoittautuivat vakavammiksi kuin aiemmin
on ajateltu, sekä yksilön että kansanterveyden tasolla. Terveyteen liittyvän elämänlaadun
mittaus väestötasolla on toteutettavissa, ja se voi tuottaa hyödyllistä tietoa väestön
terveydestä ja hyvinvoinnista.
Avansanat: Mielenterveyden häiriö; terveyteen liittyvä elämänlaatu; elämänlaatu; 15D,
EQ-5D, Suomi, väestötutkimus
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Abbreviations
15D            The 15D health-related quality of life instrument
AQoL           Assessment of Quality of Life
COPD           Chronic obstructive pulmonary disease
CLAD           Censored least absolute deviations
CVD            Cardiovascular disease
DALY           Disability-adjusted life year
DSM-IV/III-R   Diagnostic and Statistical Manual of Mental Disorders,
               4th edition / 3rd edition, revised
EBM            Evidence-based medicine
EQ-5D          The EuroQoL health-related quality of life instrument
GAD            Generalized anxiety disorder
GHQ-12         General Health Questionnaire, 12 question version
HUI            Health Utilities Index
HRQoL          Health-related quality of life
ICD-10         International Statistical Classification of Diseases and
               Related Health Problems, 10th revision
LS             Life satisfaction
M-CIDI         Munich - version of the Composite international diagnostic interview
MCID           Minimally clinically important difference
MDD            Major depressive disorder
OECD           Organisation for Economic Co-operation and Development
OLS            Ordinary least squares
QALY           Quality-adjusted life year
QWB            Quality of Well-being Index
QoL            Quality of life
PD             Panic disorder
SE             Standard error
SF-36 / SF-6D  Medical Outcomes Study Short-form HRQoL instruments
SG             Standard gamble
SES            Socio-economic status
SP             Social phobia
SRH            Self-rated health
TTO            Time trade-off
VAS            Visual analogue scale
WHO            World Health Organization
WTP            Willingness to pay
YLD            Years lived with disability
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1. Introduction
A profound change towards individualism has taken place in Western societies during the
last century. This manifests in health care as a shift from paternalism to increased
respect of the autonomy of the patient: the physician can not be the sole judge of success
or failure of health care interventions, but the opinions, values and views of patients
must be taken into account. Health for individuals is not just absence of disease or
infirmity but can, as the WHO put it, be seen as a state of complete physical,
psychological and social well-being and not merely the absence of disease or infirmity
(WHO 1946). Furthermore, diseases do not limit themselves to individuals, but may also
seriously affect the well-being of other people (Sales 2003).
This shift in health care ethics has been made a necessity by the rapid change in
demographics and disease burden in developed countries: the population has become older,
the relative burden of acutely fatal diseases has decreased and the burden of chronic
conditions has increased. Thus the relative importance for measuring mortality as an
outcome of health care has decreased and, conversely, the importance of evaluating how
people manage with several chronic conditions and disabilities has increased. In other
words, medicine has been moving from a biomedical model of curing disease towards a more
functional and resource-oriented model of improving functional capacity, health and
well-being due to both practical and ideological reasons (Nussbaum and Sen 1993;
Katschnig, Freeman et al. 2006).
A third, and the most recent driving force behind the interest in quality of life (QoL)
and health-related quality of life (HRQoL), is the rise of health economics and the
evidence-based medicine (EBM) movement. EBM emphasises the importance of using
measured, inductive evidence to justify health care decisions, instead of relying on
expert opinions or deduction from biological or other theories. EBM has increased the
importance and quality of outcome measurement in health care. Health economics on the
other hand, like Aristotle above, requires a generic, global, single-dimensional outcome
measure in order to directly compare the costs and benefits of different health care
interventions. Preference-based health-related quality of life measurement aims to meet
all these demands with quality-adjusted life years (QALYs) - a generic metric that
combines morbidity and mortality into a single index.
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Sixty years after the WHO definition of health, the interest in quality of life research
in health care has started to gain momentum and is increasing rather exponentially.
Medline finds around 1400 citations for "quality of life" before 1980, 6500 citations from
the eighties, 28000 citations from the nineties and 62000 citations from years 2000 to
2007. The promise to deliver humane, patient-centred knowledge on the effects of diseases
and health care interventions on quality of life (that would then be used to justly
maximise public well-being) is great and tempting. Several obstacles, however, still stand
in the way. The future will show whether these promises will be fulfilled. In any case,
comprehensive knowledge of the QoL impact of different conditions and disorders is a
necessary prerequisite for any attempt to rationally improve the QoL of patients.
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2. Review of the literature
2.1 Researching quality of life
2.1.1 Quality of life and values
Defining and operationalising quality of life has been neither easy nor very successful.
This is unsurprising because, from the philosophical point of view, the question of the
definition of the QoL approaches the fundamental question of ethics: the definition of a
good life or the meaning of life (Nussbaum and Sen 1993). In practice, there are hundreds
of measurement instruments for QoL, most of which have been used only sporadically
(Garratt, Schmidt et al. 2002). This, in connection with the a priori fact that there can
not be a direct way of observing what true QoL is, has left the field without a gold
standard. A popular way of overcoming these difficulties is to use a multi-dimensional
definition of QoL including many, if not all, things that can be beneficial for
well-being, for example 1) subjective satisfaction or happiness, 2) ability to function
(physical, mental and social) and 3) availability of necessary resources (material
standard of living, social support) (Katschnig, Freeman et al. 2006). A more
philosophically oriented approach would be to separate three kinds of theories of the good
life: 1) hedonist theories, emphasising some form of (positive) conscious emotion or
feeling, 2) preference satisfaction theories, emphasising the fulfilment of personal
preferences or desires and 3) ideal theories, concentrating on fulfilment of other
normative ideals than those aforementioned (Brock 1993).
Developing quality of life measures is in reflexive relation to our own view of QoL: our
ideals about what constitutes a good quality life guides the beginning of the development
process, but the practical issues inherent in all measure-development then start to
influence the measures. Further, the most popular measures may eventually start to
influence our understanding of the original construct. Developing quality of life measures
is thus a fundamentally value-laden, normative process (Chisholm, Healey et al. 1997;
Murray, Salomon et al. 2000).
2.1.2 Health-related quality of life and health state preferences
It is obvious that health is only one, although important, determinant of quality of life
(Bowling 1996). Health-related quality of life (HRQoL) is a more narrow concept than QoL;
HRQoL tries to capture the aspects of QoL that health, and ideally also health care, can
influence. Of the three components of QoL mentioned above, HRQoL instruments generally
concentrate on functional capacity. Thus HRQoL is in theory a more practical way of
measuring the impact of different diseases than QoL.
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Quality-adjusted life year (QALY) is a metric that combines mortality and morbidity into a
single index score. This is important for comparisons between different diseases and
treatments. Preference-based generic HRQoL measures, such as the 15D and the EQ-5D used in
this study, form the quality-component of QALYs. In practice they are multi-attribute
utility scales, which means that they consist of several dimensions that can be combined
into a single summary score using preferences of real people for certain health states
(Dolan 2000). The preferences are anchored at death (HRQoL=0) and full health (HRQoL=1)
in order to allow combination with mortality. The most favoured methods for preference
elicitations are time trade-off (TTO) and standard gamble (SG). They require the
respondents to estimate how many life years they would give up (TTO) or how large a risk
of sudden death they would accept (SG) in order to be in full health in comparison to
another health state. The resulting preference score is commonly referred to as health
utility. Preferences can also be elicited using visual analogue scale (VAS) by, for
example, anchoring the scale at "best possible QoL" and "worst possible QoL". Furthermore,
the willingness to pay (WTP) method investigates how much people would be willing to pay
for certain health outcomes. This incorporates monetary values directly into the process
of health state valuation (Fayers and Machin 2007). Preferences can be elicited from
people who are in health states to be valued or have at least sometimes experienced them,
or from healthy people who have to imagine being in the health states to be valued. There
is no gold standard for how and from whom the valuations should be elicited. Both 15D and
EQ-5D use health preferences elicited from the general population. This assumes that
preferences do not vary between different groups of people; especially between patients
and healthy people, or people at different ages.
There is also no gold standard for HRQoL measurement, nor for preference
elicitation. Hundreds of HRQoL measures with different properties are in use (Garratt,
Schmidt et al. 2002), and even those with preference-based scoring systems often produce
conflicting results (Tengs and Wallace 2000; Hawthorne, Richardson et al. 2001; Kopec and
Willison 2003). The major HRQoL measures based on multi-attribute utility theory are
listed in the appendix.
There are also competing approaches to measuring quality-adjusted survival (i.e. combining
morbidity and mortality). The most popular alternative is disability-adjusted life years
(DALY), made famous by the Global Burden of Disease (GBD) studies (Murray and Lopez
1996) and then used in several local settings (Peterson, Backlund et al. 1998; Mathers,
Vos et al. 1999; Melse, Essink-Bot et al. 2000). The DALY method combines separately
collected prevalence data and disability weights for different diseases. The weights are
generally collected from experts who value different diseases, and generally assumed to be
constant (i.e. all states of a disease are taken to be equally severe). This contrasts
with the QALY approach that measures prevalence and health states simultaneously, allowing
for the true variation in disease severities, and uses population preferences for health states.
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Obviously, the best method for summarising population health depends on the purpose of the
measurement and the data available; all methods make fundamental assumptions that can be
contested, and all datasets are imperfect. DALYs were originally used to describe the
burden of disease globally with a very heterogeneous database. From the health economic
perspective however, the key interest lies in investigating the marginal benefits of
health interventions and health care systems. This information is highly policy-relevant,
as it could be used for optimizing the functioning of health care - for example via
rationing decisions and health technology assessment. The QALY approach, starting with
people and not with disease, appears more suitable for health economic analysis, and could
even be used at individual level - for example, as an outcome in a pay-for-performance
system. Furthermore, QALYs can also be used for describing burden of disease if the data
are available (Williams 1999; Mooney and Wiseman 2000; Murray and Lopez 2000; Williams
2000).
2.2 Surveys measuring HRQoL and chronic conditions
In order to compare the burden of different diseases and conditions using health utilities
or QALYs, a representative population sample, utility-based health measurement and
reliable diagnostics are needed. As very few studies fulfil all three - especially when it
comes to psychiatric disorders - the literature review is limited to studies fulfilling
the first two criteria. Studies identified are presented in Table 1. Comparing different
studies still requires caution, as different HRQoL measures may yield different results
despite being utility-based (Tengs and Wallace 2000). Also, the surveys have different
samples, response rates, statistical methods and diagnostic procedures.
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Table 1. General population surveys estimating health utility losses of chronic conditions.
  Reference        N (response rate)   HRQoL         Somatic diagnostics,                       Psychiatric             Results          Comment
                   age, country        measurement   included conditions                        diagnostics,
                                                                                                included conditions
  Burström         Sample = 4 950      EQ-5D         Self-reported by questionnaire:            "Mental distress"       Diabetes         Results
  2001b            (resp. rate 63%)    (UK TTO)      Diabetes as diagnosed by physician         (defined as 2/12 or     -0.060           adjusted
  (Burström,       20-88 years                       ("diabetes"), "asthma", use of             more problems GHQ-     Mental distres   with linear
  Johannesson      Sweden                            antihypertensive medications               12, prevalence 21%)     -0.125           regression
  et al. 2001)                                       ("hypertension"), chest pain during                                Hypertension     for
                                                     activity within last 12 months ("angina                            -0.022           age, gender,
                                                     pectoris"), "neck/shoulder pain" or                                Angina pectoris   SES, other
                                                     "low back pain" (if pain more than                                 -0.045           conditions
                                                     twice a week during last 6 months)                                 Asthma
                                                                                                                        -0.021
                                                                                                                        Neck/shoulder
                                                                                                                        pain
                                                                                                                        -0.081
                                                                                                                        Low back pain
                                                                                                                        -0.115
  Lubetkin         13200               EQ-5D         Self-reported by interview: Diabetes,      -                       Diabetes         Results
  2005             respondents         (USA TTO)     asthma, high blood pressure,                                       -0.041           adjusted
  (Lubetkin, Jia   (resp. rate ~56%)                 emphysema, stroke or TIA ("stroke")                                Hypertension     with
  et al. 2005)     18+ years                         or "heart disease" (including coronary                             -0.046           linear
                   USA                               heart disease, angina, heart attack or                             Heart disease    regression
                                                     other heart condition)                                             -0.059           for
                                                                                                                        Asthma           age, gender,
                                                                                                                        -0.038           race, SES,
                                                                                                                        Stroke           other
                                                                                                                        -0.056           conditions
                                                                                                                        Emphysema
                                                                                                                        -0.076
  Barton 2007      Sample = 2770       EQ-5D         Self-reported by questionnaire: back       -                       Back pain        Results
  (Barton, Sach    (resp. rate 63%)    (UK TTO)      pain, hip pain, knee pain (on most days                            -0.155           adjusted
  et al. 2007)     45+ years                         of the last month), diagnosed with heart                           Hip pain         with
                   UK                                disease, stroke, asthma, cancer,                                   -0.110           linear
                                                     diabetes, rheumatoid arthritis or                                  Knee pain        regression
                                                     osteoarthritis)                                                    -0.111           for
                                                                                                                        Heart disease    age, gender,
                                                                                                                        -0.052           race,
                                                                                                                        Stroke -0.074    education,
                                                                                                                        Asthma -0.032    BMI,
                                                                                                                        Cancer -0.024    smoking, other
                                                                                                                        Diabetes         conditions
                                                                                                                        -0.058
                                                                                                                        Rheumatoid
                                                                                                                        arthritis
                                                                                                                        -0.102
                                                                                                                        Osteo-
                                                                                                                        arthritis
                                                                                                                        -0.079
  Johnson 2000     Sample = 4200       EQ-5D         Self-reported by questionnaire:            "depressive feelings":                    Only raw
  (Johnson and     (resp. rate 37%)    (UK TTO)      Arthritis/rheumatism, asthma, cancer,      Defined by question                      scores
  Pickard          18+ years                         emphysema/bronchitis, diabetes,            ’how often in the past                    reported
  2000)            Canada                            glaucoma, ulcers, high blood pressure,     four weeks have you
                                                     heart disease, epilepsy.                   felt depressed?’ with
                                                                                                5  response options,
                                                                                                ’none’ to ’all of the
                                                                                                time’, categorized at
                                                                                                3/5. Prevalence 18.6%
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  Reference        N (response rate)   HRQoL         Somatic diagnostics,                       Psychiatric             Results          Comment
                   age, country        measurement   included conditions                        diagnostics,
                                                                                                included conditions
  Sullivan 2005    Sample = 93380      EQ-5D         Self-reported in interview, open           Self-reported in        Examples:        Adjusted with
  (Sullivan,       (resp. rate 41%)    (USA TTO)     question. Over 100 classes of chronic      interview, including,   Senility and     CLAD
  Lawrence         18+ years                         conditions (lasting over 1 year)           for example:            organic mental   regression
  et al. 2005)     USA                               included.                                  "Alcohol-related        disorders        for age,
                                                                                                mental disorders"       -0.175           gender, race,
                                                                                                (0.19 %)                Parkinson’s      ethnicity,
                                                                                                "Affective disorders"   -0.111           income,
                                                                                                (1.04 %)                Rheumatoid       education,
                                                                                                "Anxiety,               arthritis        number of
                                                                                                somatoform,             -0.085           chronic
                                                                                                dissociative, and       Affective        conditions
                                                                                                personality disorders"   disorders
                                                                                                (6.36 %)                -0.074
                                                                                                                        Osteoarthritis
                                                                                                                        -0.061
                                                                                                                        Congestive
                                                                                                                        heart failure
                                                                                                                        -0.055
                                                                                                                        Anxiety,
                                                                                                                        somatoform,
                                                                                                                        dissociative,
                                                                                                                        personality
                                                                                                                        disorders
                                                                                                                        -0.042
                                                                                                                        Alcohol-related
                                                                                                                        disorders
                                                                                                                        -0.002 (n.s.)
  Fryback 1993     Sample = 1700       Quality of    28 conditions, asked separately in         "depression"            Congestive       QWB scores
  (Fryback,        (Resp rate 80%)     Well-being    interview, included if bothered in         (12 month               heart failure    age-adjusted
  Dasbach          Age 45-89           Index (QWB),  last 12 months.                            prevalence 4,6%)        -0.10            with linear
  et al. 1993)     Beaver Dam, WI,     TTO                                                      "anxiety" (4.0%)        Myocardial       regression
                   USA                                                                          "sleep disorder"        infarction       to sample
                                                                                                (10.0%)                 -0.09            mean of 64
                                                                                                                        Depression       years
                                                                                                                        -0.08
                                                                                                                        Angina
                                                                                                                        pectoris
                                                                                                                        -0.07
                                                                                                                        Anxiety -0.05
                                                                                                                        Sleep disorder
                                                                                                                        -0.05
  Mittmann, N      Sample = 17 626     Health        Interview, 22 chronic conditions asked     -                                        No age-
  1999             (Resp. rate n.a.)   utilities     separately (if diagnosed by a                                                       adjusted
  (Mittmann,       12+ years           index         professional).                                                                      results
  Trakas           Canada              (HUI) mark                                                                                        reposted
  et al.                               III
  1999)
  Schultz 2003     Sample = 73 402     HUI,          Interview, 21 chronic conditions were      -                       Alzheimers       Results
  (Schultz and     (Resp. rate 79%)    mark III      asked separetely (if diagnosed by a                                disease          adjusted
  Kopec 2003)      12+ years                         professional)                                                      -0.34            with
                                                                                                                        Stroke           linear
                                                                                                                        -0.17            regression
                                                                                                                        Urinary          for
                                                                                                                        incontinence     age, gender
                                                                                                                        -0.13            and other
                                                                                                                        Arthritis/       chronic
                                                                                                                        rheumatism       conditions
                                                                                                                        -0.09
                                                                                                                        Chronic
                                                                                                                        bronchitis/
                                                                                                                        emphysema
                                                                                                                        -0.08
                                                                                                                        Cataract
                                                                                                                        -0.08
                                                                                                                        Back problems
                                                                                                                        -0.06
                                                                                                                        Heart disease
                                                                                                                        -0.06
                                                                                                                        Diabetes -0.06
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  Reference        N (response rate)   HRQoL         Somatic diagnostics,                       Psychiatric             Results          Comment
                   age, country        measurement   included conditions                        diagnostics,
                                                                                                included conditions
  Manuel 2002      Sample = 48 770     HUI,          Telephone interview, 20 chronic            "Mental disorder" as    Age-adjusted     Population
  (Manuel,         (Resp. rate 73%)    mark III      conditions asked separately + open         diagnosed with CIDI     HUI scores:      mean scores
  Schultz et al.   18+ years                         question, categorized in 11 groups         DSM-III-R 12-month      (female/male)    n.a.
  2002)            Ontario, Canada                                                              depression prevalence   Injuries
                                                                                                questions. Prevalence   0.76/0.79
                                                                                                ~4%                     Mental disorder
                                                                                                                        0.85/0.85
                                                                                                                        Musculoskeletal
                                                                                                                        disorders
                                                                                                                        0.88/0.90
                                                                                                                        Heart disease
                                                                                                                        0.90/0.90
                                                                                                                        Respiratory
                                                                                                                        disorders
                                                                                                                        0.93/0.93
  Isacson          Respondents =       TTO           Mail questionnaire, separately             "Depression" (if        Depression       Results
  2005(Isacson,    3986,                             mentioned: headache, backache/ache in      feeling depressed on    -0.090           adjusted
  Bingefors et     (resp. rate 60%)                  legs, arms, shoulders, asthma, diabetes,   the day filling the     Diabetes         with
  al. 2005)        20-64 years                       angina, hypertension, dermatological       questionnaire,          -0.047           linear
                   Sweden                            problems, problems in the urinary tract,   prevalence of 3.8%)     Anxiety          regression
                                                     gastrointestinal problems                   "anxiety" (prevalence   -0.045           for
                                                                                                12.5%)                  Sleeping         age, gender
                                                                                                "sleeping disorder"     disorder         and other
                                                                                                (prevalence 18.4%)      -0.034           conditions
                                                                                                                        Hypertension
                                                                                                                        -0.033
                                                                                                                        Gastrointesti-
                                                                                                                        nal problems
                                                                                                                        -0.026
  Wells 1999       Sample = 33 932     TTO, SG       Self-report current conditions, asked      "12-month MDD"          Depression       Results
  (Wells and       (Resp. rate 52%)                  separately: asthma, diabetes,              (prevalence 19.8%),     -0.079/-0.036    adjusted
  Sherbourne       18+ years                         hypertension, arthritis, migraine,         "12-month double        (TTO/SG)         with
  1999)            Managed primary                   chronic lung problems, neurological,       depression" (5.3%),     Neurological     linear
                   care patients                     heart, gastrointestinal tract, vision or   "12 month               problems         regression
                   with                              back problems.                             dysthymia" (0.9%),      -0.047/-0.035    for
                   mental health                                                                "lifetime bipolar       GI tract         age, gender,
                   insurance, USA                                                               disorder" (1.9%),       problems         education,
                   (not a general                                                               1-month depressive      -0.040/n.s.      ethnicity,
                   population                                                                   symptoms (5.6%):        Diabetes         other
                   survey)                                                                      self-report by          -0.022/-0.033    conditions.
                                                                                                questionnaire,          Arthritis
                                                                                                containing              -0.016/-0.012
                                                                                                5 questions             Migraine
                                                                                                from CIDI depression    -0.014/-0.015
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2.2.1 Comparing the severity of different conditions
Few  comprehensive  surveys have  compared the  relative HRQoL impact of several chronic
conditions using multi-attribute utility-based HRQoL measures (EQ-5D, Quality of
Well-being Index, QWB, Health Utilities Index, HUI, Assessment of Quality of Life AQoL,
SF-6D, Rosser-Kind Index) or using direct valuation methods (TTO or SG) (Fryback, Dasbach
et al. 1993; Johnson and Coons 1998; Mittmann, Trakas et al. 1999; Johnson and Pickard
2000; Burström, Johannesson et al. 2001; Burström, Johannesson et al. 2001; Manuel,
Schultz et al. 2002; Schultz and Kopec 2003; Lubetkin, Jia et al. 2005).
Measured with EQ-5D, a Swedish study investigating seven conditions found that the largest
decreases in HRQoL were associated with mental distress, low back pain and neck/shoulder
pain (Burström, Johannesson et al. 2001). A UK study including ten conditions (five of
which were musculoskeletal) found the most severe conditions to be back, knee and hip pain
and rheumatoid arthritis (Barton, Sach et al. 2007). A US study containing six conditions
ranked emphysema, heart disease and stroke as having the greatest age-adjusted HRQoL
impact (Lubetkin, Jia et al. 2005). Another larger US study considering over 100
conditions ranked mental retardation, senility and organic mental disorders, spinal cord
injury, multiple sclerosis and paralysis as the most severe. Considering conditions
included in our study, the most severe were Parkinson’s disease, rheumatoid arthritis,
affective disorders, osteoarthritis and congestive heart failure (Sullivan, Lawrence et
al. 2005).
A Canadian study using the HUI found that the greatest losses of HRQoL were associated
with Alzheimer’s disease, stroke and urinary incontinence (Schultz and Kopec 2003).
Another Canadian study using wider diagnostic groupings found that the lowest age-adjusted
HUI scores were associated with injuries, depression and musculoskeletal disorders
(Manuel, Schultz et al. 2002).
Using Quality of Well-being Index in a US sample, the largest losses of HRQoL were
observed in persons reporting heart failure, myocardial infarction and depression
(Fryback, Dasbach et al. 1993).
In addition to using multi-attribute utility instruments like 15D, EQ-5D and HUI, health
utility losses associated with different conditions can also be estimated using different
direct valuation techniques, for example the standard gamble (SG) or time trade-off (TTO)
(Dolan 2000). A Swedish postal survey (Isacson, Bingefors et al. 2005) using a TTO
exercise and self-reported conditions found that feeling depressed on the current day was
clearly the most severe of the included 12 conditions, followed by self-reported anxiety.
Similar results were found by a large US study of managed primary care patients (Wells and
Sherbourne 1999) that used both SG and TTO exercises, self-reported somatic conditions and
12-month depression diagnosis based on selected CIDI questions. It found that depression
was associated with clearly the largest loss of health utility, in comparison to the 11
included somatic conditions.
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2.2.2 Age and the impact of conditions
Whether the severity of conditions varies by age has theoretical and practical importance.
Although it is not very important for QALY approach used in this study, it is essential
for the other popular method of estimating the burden of diseases, the disability-adjusted
life years (DALY) method (Gold, Stevenson et al. 2002). The DALY method combines
separately collected prevalence data and disability weights, whereas the QALY approach
uses specific population studies. In practice, the disability weights are usually assumed
to be constant, i.e. all instances of a disease are considered to be equally disabling. In
theory, the disability weights could be stratified by the same covariates (such as age,
sex, severity of the condition) that the prevalence can be stratified. However, as this is
burdensome, it is important to know for which conditions age-stratified disability weights
and prevalence information are actually needed - i.e. whether the severity of conditions
varies significantly by age.
None of the surveys reviewed in Table 1 focus on the issue of whether the health utility
impacts of conditions vary by age. Only two of the surveys reported the HRQoL losses
separately for different ages. The first of these (Fryback, Dasbach et al. 1993) using the
Quality of Well-being Index in USA reported age-stratified scores for some chronic
conditions, but the authors did not comment on the age-related differences. No statistical
testing was reported, and no clear age-related trends in QWB scores were observed in
comparison to controls. The latter study (a Canadian study using the HUI) (Schultz and
Kopec 2003) concluded that the impact of chronic conditions on HRQoL is not the same at
all ages, and the authors noted that conditions such as bowel problems or chronic
bronchitis seem to have a greater effect on older individuals’ quality of life. The
severity of stroke, migraine and stomach/intestinal ulcers also seemed to increase with
age, but no statistical testing was reported.
A study using direct TTO exercise and 12 self-reported conditions (Isacson, Bingefors et
al. 2005) estimated the relative impact of depression in comparison to the other
conditions, stratified by age. In their study, depression accounted for 11% of the health
utilities lost due to disability identified. The proportion of all health utilities lost
associated with depression decreased from 15% at ages 35-44 (prevalence 4.6%, difference
in mean utilities between depressed and non-depressed -0.16) to 5% at ages 55-64
(prevalence 3%, difference of 0.07), suggesting both possible causes for the decreasing
burden of depression by age: decreased prevalence and decreased severity (absolutely
and/or relative to increased utilities lost due to other conditions).
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2.2.3 Mental disorders and health-related quality of life
The only survey from Table 1 that included several psychiatric conditions and HRQoL
instrument (Sullivan, Lawrence et al. 2005) found that self-reported "affective disorders"
were associated with larger health utility loss (loss of -0.07 on EQ-5D) than "anxiety,
somatoform, dissociative or personality disorders" (-0.04). "Alcohol-related disorders"
did not associate with a statistically significant impact on the EQ-5D.
Two studies using direct valuation method came to almost identical conclusions: The
Swedish postal survey (Isacson, Bingefors et al. 2005) using a TTO exercise estimated 0.09
lost utilities for depression, and -0.045 for anxiety. Diagnoses were based on
self-report, and controlled for other somatic and psychiatric conditions (depression,
anxiety, sleep disorder). A large US study of managed care patients (Wells and Sherbourne
1999) using both SG and TTO exercises found probable 12-month MDD to be associated with
loss of 0.08 health utilities on TTO and 0.04 on SG. The study diagnostics was based on
seven self-reported CIDI depression and mania questions, and the authors made provisional
diagnoses of other 12-month affective disorders as well. This showed that double
depression (MDD and dysthymia) was the most severe condition (-0.13 and -0.07 utilities on
TTO and SG, respectively), in comparison to dysthymia only (-0.08/n.s.) or MDD only
(-0.05/-0.02). This study did not include, and thus did not control for, other psychiatric
disorders.
2.2.4 Surveys investigating alcohol consumption, HRQoL and other measures
of well-being
2.2.4.1 Mortality, J-curve and HRQoL
There are several studies investigating the association between mortality and alcohol
consumption. For example, a recent meta-analysis found robust evidence of reduced risk of
mortality associated with moderate alcohol consumption and increased risk associated with
heavy consumption and abstaining (Di Castelnuovo, Costanzo et al. 2006). This is commonly
referred to as the J-curve between alcohol consumption and mortality. However, it is
unclear whether this J-curve applies to HRQoL as well.
The meta-analysis (Di Castelnuovo, Costanzo et al. 2006) also investigated the subgroup of
studies that had tried to separate former drinkers or very light drinkers from abstainers,
and found that this significantly reduced - but did not eliminate - the benefits of
moderate alcohol consumption. However, one meta-analysis using very strict inclusion
criteria did not find this (Fillmore, Kerr et al. 2006; Fillmore, Stockwell et al. 2007).
This study concluded that only seven of the 54 studies included were not misclassifying
former drinkers or very low drinkers as abstainers. Beneficial effects of moderate alcohol
consumption on mortality were observed only in those studies including some kind of
classification error. The seven studies using most rigorous classification of abstainers
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found no statistically significant benefits of moderate alcohol consumption. However, as
this meta-analysis was very strict and excluded most of the studies conducted on the
topic, the results are difficult to interpret and some uncertainty remains over the health
benefits of alcohol (Eigenbrodt, Fuchs et al. 2006). Generally, there appears to be a
consensus, based on epidemiological and biological data, that moderate alcohol consumption
decreases the risk of coronary heart disease (Rimm and Moats 2007). However, whether this
reduction is associated with clinically important improvement of HRQoL or other aspects of
QoL is unclear. Studies on the topic are complicated by the fact that former drinkers have
higher risk of mortality, morbidity, low socioeconomic status and poor health behaviours
in comparison to other abstainers. Thus pooling all abstainers as one group is likely to
exaggerate the benefits of moderate alcohol consumption in comparison to abstaining
(Fillmore, Golding et al. 1998; Gmel, Gutjahr et al. 2003).
General population surveys have not examined the benefit or harm of alcohol consumption
using utility-based HRQoL measures. Considering surveys using HRQoL measures other than
utility-based, a US study using SF-36 found that "non-current" drinkers reported poorest
mental and physical health, although the difference compared to lifetime abstainers was
small and not statistically significant (Stranges, Notaro et al. 2006). The US study did
not find consistent differences between lifetime abstainers and current drinkers. In
contrast, a Dutch study similarly using the SF-36 found that former drinkers had in
general intermediate scores between other abstainers and drinkers (van Dijk, Toet et al.
2004). On mental health, former drinkers actually scored best, but otherwise the best
scores were observed for light and moderate drinkers. However, even excessive drinkers
(men drinking over 42 drinks and women over 28 drinks per week) had better health than
abstainers. No explicit questions about quitting drinking or past alcohol problems were
asked. A Japanese study on healthy male workers using five SF-36 subscales and explicitly
asking about former drinking status found former drinkers to have general health scores
below, and current drinkers to have vitality scores above, those of long-term abstainers
(Saito, Okamura et al. 2005). No other subscales were statistically significant when
background variables were controlled for. There was no trend for worse scores for heavy
drinkers (>483g/week) on any of the SF-36 subscales. However, the study is problematic as
it is limited to healthy workers, meaning that people with largest alcohol-related and
other problems are excluded. In sum abstainers, especially those who are former drinkers,
appear to have problems on some domains of HRQoL in comparison to moderate drinkers.
Surprisingly however, none of the previous surveys found negative association of heavy
alcohol consumption and HRQoL.
2.2.4.2 Other domains of well-being
A recent review of the literature on moderate drinking, health and well-being identified
several studies with widely varying categorizations of drinkers and explanatory variables
(El-Guebaly 2007). The review identified five surveys investigating self-rated health and
moderate alcohol consumption, with four finding a J-curve and one finding the health
benefits of alcohol extend to heavy alcohol use. It also identified three studies
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concerning general mental health, each finding moderate alcohol users to have the best
general mental health. Some studies have examined "Life satisfaction" (LS). A pioneering
survey in USA examined satisfaction with several areas of life but, after accounting for
confounding socioeconomic variables, almost no associations between alcohol consumption
and LS were found (Hingson, Scotch et al. 1981). A previous Finnish survey noted a
J-formed relationship between LS and alcohol consumption, but this was before any
adjustments (Koivumaa-Honkanen, Honkanen et al. 2000). A British study using several
psychological measures found that GHQ scores (controlling for age, social class and
smoking) were best for light drinking men, in comparison to abstainers and heavy drinkers,
but this was not found for women (Roberts, Brunner et al. 1995). In sum, moderate drinking
seems to be associated with improved well-being, at least if socioeconomic factors and
former drinking are not controlled for.
Regarding self-rated health (SRH), a Dutch study found that abstainers and heavy drinkers
had worse SRH than light or moderate drinkers (San Jose, van de Mheen et al. 1999).
According to Australian data on the number of alcoholic drinks per day, those with no
drinks or with over three daily drinks had worse SRH than light or moderate drinkers
(Wang, Smith et al. 2006). A Spanish study found that all drinking groups (up to over 7
drinks / day) had better SRH than abstainers (Guallar-Castillon, Rodriguez-Artalejo et al.
2001). These studies however, did not differentiate between different groups of
abstainers. A British study that tried to address the former drinker-problem found that
light and moderate drinkers (0-20 drinks per week for women and 0-35 drinks for men) had
better self-rated health and less psychological distress than heavy drinkers and
abstainers at the age of 33. There were no differences between models including and
excluding problem drinkers, but results for problem drinkers were not reported separately
and no adjustments for socioeconomic factors were made (Power, Rodgers et al. 1998). A
previous Finnish general population survey examining the odds of good self-reported health
did not find ex-drinkers to differ from lifetime abstainers, but those who had
deliberately decreased their alcohol intake had poorer health (Poikolainen, Vartiainen et
al. 1996). Improved SRH was best at consumptions between 40-99g (3-8 drinks) per week,
and SRH was decreased at consumptions exceeding 300g (25 drinks) per week (adjusting for
sociodemographic factors). A similar large US survey (French and Zavala 2007) found that
moderate drinking men (4-14 drinks per week) had increased odds of good SRH in comparison
to abstainers, as had women who had drank more than 12 drinks in the last year. Moderate
drinking women had best SRH. Former drinkers did not differ from other abstainers, but
former drinkers included anyone who had drunk over 12 drinks per year but abstained for
the last year. A previous Finnish study found that the labour market underperformance of
male abstainers was almost entirely due to some abstainers being former drinkers
(Johansson, Alho et al. 2006). These results support the view that those abstainers who
have quit drinking are doing more poorly than other abstainers on a very broad range of
measures.
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3. Aims of the study
This study aimed to measure the utility-based HRQoL losses associated with common chronic
somatic conditions, reliably diagnosed psychiatric conditions and different alcohol
consumption patterns in Finland, using two established HRQoL measures.
The study consists of four original publications, the aims of which were:
I    To investigate the individual-level HRQoL impact of 29 chronic conditions, including
       reliably diagnosed psychiatric disorders in the Finnish general population and to estimate
       the public health impact of these 29 chronic conditions, using QALYs lost due to
       morbidity.
II    To estimate how the individual severity (HRQoL) and public health impact (QALYs lost to
       morbidity) of these conditions varies at different ages, and to predict how the ageing of
       the Finnish population affects the QALYs lost due to morbidity.
III  To investigate the HRQoL and QALY losses associated with depressive and anxiety
       disorders and alcohol dependence, and to examine which domains of HRQoL are lost in
       these psychiatric disorders.
IV   To investigate how the amount of alcohol consumed relates to HRQoL, and to test,
         whether those abstaining from alcohol consist of two different groups in relation to
         HRQoL: those who have quit using alcohol for some reason, and others.
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4. Subjects and methods
4.1 The Health 2000 survey
4.1.1 The sampling and data gathering
This study is based on the Health 2000 survey, a comprehensive health interview and
examination survey that was carried out in Finland from autumn 2000 to spring 2001. The
National Public Health Institute had the main responsibility for the survey, with other
Finnish social and health care organisations participating. The main aim of the Health
2000 survey was to obtain information on the most important public health problems in the
country, their causes and treatment as well as on the population’s functional and working
capacity (Aromaa and Koskinen 2004). The methods of the survey and baseline reports have
been published and are available on the internet at www.ktl.fi/terveys2000.
The survey is based on two-stage stratified cluster sampling design, consisting of 8028
people aged 30 years and over and living in mainland Finland. The sampling frame was first
regionally stratified to five university hospital regions. From each of these regions, 16
health care districts were sampled as clusters, yielding altogether 80 health care
districts in the whole country. The 15 largest health centre districts were included in
the sample, and the remaining 65 health centre districts were selected by systematic
probability proportional to size sampling. From each of these 80 health centre districts,
persons were selected by systematic sampling. Persons aged 80 years and over were
oversampled by doubling the sampling fraction. For the 15 largest health centre districts
that were all included, the sample sizes were proportional to population size. In the
remaining 65 health care districts the sample sizes were equal within each university
hospital region, so that the total number of persons drawn from a university hospital
region was proportional to the corresponding population size (Aromaa and Koskinen 2004).
The study was approved by the ethics committee of the National Public Health Institute and
the Hospital District of Helsinki and Uusimaa.
The survey consisted of the following parts:
1.   Interview at home (or institution),
2.   Health examination at the local health centre,
3.   Several self-report questionnaires,
4.   Interview and a health examination of non-respondents at home (or institution),
5.   Telephone interview and/or a mail questionnaire of remaining non-respondents and,
6.   Gathering of register information on the whole sample.
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The interview was used to gather, among other things, basic background and
sociodemographic information, information about health and illnesses as well as use of
medicines, use of health services and health-related behaviour. The interviewers left a
questionnaire (questionnaire 1) that participants were asked to bring with them to the
health examination. The health examination included a thorough health and dental
examination and several laboratory tests. It also contained a computer assisted mental
health interview, the Munich version of the Composite International Diagnostic Interview
(M-CIDI) (Wittchen and Pfister 1997; Wittchen, Lachner et al. 1998). After the health
examination, the participants received further questionnaires (questionnaires 2 and 3) to
be filled in directly or later and mailed to the National Public Health Institute.
Reminders were sent to non-respondents. All questionnaires and the interviews are
available at www.ktl.fi/terveys2000 and the methods are described in detail in Heistaro
2005.
4.1.2 Sociodemographic factors
The age and gender were available for all 8028 people sampled from register data. In the
analyses, age was classified into six groups, 30-44, 45-54, 55-64, 65-74, 75-84 and 85
years and over, as there is no reason to presume the relationship between HRQoL and age to
be linear. Other sociodemographic information was obtained at the home interview.
Education was classified as basic, secondary or higher. Those who had completed vocational
school, or who had passed the matriculation examination were classified as having
secondary education. Degrees from higher vocational institutions, polytechnics and
universities were classified as higher education. Self-reported family income was adjusted
for family size using the OECD formula (OECD 1982) in which the first adult of a family is
weighted as 1.0, other adults as 0.7, and children less than 18 years old as 0.5. Marital
status was classified to those married or cohabiting, and others.
4.1.3 Somatic conditions
Participants were asked in the home interview whether they had ever been diagnosed by a
physician with any of 43 specified diseases and conditions. If they answered yes,
additional questions about time of diagnosis, treatments, visits to a physician and
condition-specific issues were asked. Twenty-five somatic conditions were included in this
study, based on their public health importance, chronic nature and the reliability of
self-report diagnostic classification. The disorders included and their prevalence is
reported in Table 2. Problems with back or neck and disturbing allergy were considered
only if the participant had visited a doctor for this condition during the past 12 months.
Only unoperated cataract was considered. For Study II, the conditions were categorised to
nine clinically relevant and mostly ICD-10 based categories (Table 2.)
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Table 2. Categorisation of conditions included in the study, their prevalence,
proportion of women and mean age1.
  Groups of conditions (Study II)         Conditions (Study I)                      Prevalence, %          Proportion        Age,
                                                                                                           women, %          mean
  Cardiovascular disorders                Coronary heart disease                            8.3                47            70
                                          Heart failure                                     4.5                63            73
                                          Hypertension                                     30.9                53            59
  Musculoskeletal disorders               Arthrosis of hip or knee                         12.6                60            64
                                          Back problems                                     7.5                54            52
                                          Neck problems                                     5.1                67            53
                                          Other arthrosis                                   8.9                60            60
                                          Rheumatoid arthritis                              3.2                66            65
  Neurological disorders                  Migraine                                          7.6                76            51
                                          Parkinson’s disease                               0.5                46            72
                                          Stroke                                            2.8                48            70
  Problems of hearing                     Loss of hearing                                  16.0                41            61
                                          Tinnitus                                         12.0                43            60
  Psychiatric disorders                   Alcohol use disorders                             4.2                18            45
                                          Anxiety disorders                                 4.2                59            49
                                          Depressive disorders                              6.5                66            49
                                          Psychosis                                         1.3                61            51
  Pulmonary disorders                     Chronic obstructive pulmonary disease             5.9                51            60
                                          Asthma                                            8.8                62            57
  Problems of vision                      Cataract                                          3.3                73            72
                                          Glaucoma                                          3.1                74            69
                                          Macular degeneration                              3.3                66            71
  Other disorders                         Cancer                                            4.9                70            66
                                          Diabetes                                          5.9                53            64
                                          Inflammatory bowel disease                        2.2                64            58
                                          Psoriasis                                         2.3                42            54
                                          Urinary incontinence                             13.0                77            64
                                          Disturbing allergy                                5.1                65            49
  Disability caused by accident           Disability caused by accident                    13.5                36            57
1  Prevalence, age and proportion women are weighted to represent the Finnish population aged 30 and over
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4.1.4 Psychiatric diagnostics
At  the  health  examination  the  participants  attended a  structured mental health interview,
which used the Finnish translation of the German computerised version of the Composite
International Diagnostic Interview (M-CIDI) (Wittchen and Pfister 1997; Wittchen, Lachner
et al. 1998). It was used to assess 12-month prevalence of depressive, anxiety or alcohol
use disorders and lifetime prevalence of alcohol dependence (Pirkola, Isometsä et al.
2005) using DSM-IV (1994) criteria. This study includes depressive disorders (major
depressive disorder (MDD), dysthymia) alcohol dependence and abuse, and anxiety disorders
(agoraphobia, generalized anxiety disorder (GAD), panic disorder (PD) and social phobia
(SP)). Psychosis was diagnosed, if the participant self-reported suffering from psychosis
or the physician conducting the health examination considered the participant had a
probable psychotic disorder.
4.1.5 Alcohol consumption
Alcohol use was measured in questionnaire 1 with questions in which the participants were
asked to report their average weekly consumption of 1) beer, cider and long drinks, 2)
spirits and 3) wine during the past month. The results were converted into grams of
alcohol per week. The intention was to group participants into equally sized deciles based
on their alcohol use. However, as there were more than 10% of abstainers and the scale was
not fully continuous in the lowest end, it was impossible to achieve 10 equally sized
groups. As women belonging to the highestdrinking decile still drank relatively little
(mean 214 g/week, little over 2 drinks / day) the highest decile was divided in two
groups. In addition, the participants were asked whether they a) have been teetotal for
their entire life (or tasted alcohol maximum ten times) b) have used alcohol earlier, but
then quit, or c) use alcohol currently. The frequency of drinking during the last year was
assessed.
Abstainers, i.e. those who had not drunk during the past month, were first classified into
two groups: "former drinkers", including abstainers who said they have used alcohol
earlier but since quit and those who received a lifetime diagnosis of an alcohol use
disorder. The rest were classified as "other abstainers". In order to investigate the
effect of the length of the abstaining period, former drinkers and other abstainers were
categorized into six groups with regards to a) alcohol-related diagnoses and b) having
drank alcohol during the last year, but not the last month.
Study IV excluded people aged 65 or over, as alcohol can be assumed to affect the elderly
and working aged populations differently. Furthermore, due to mortality and the common
decline in alcohol consumption with age, old people become a rather selected group
especially regarding heavy alcohol consumption and health. Pregnant women (N=31) were also
excluded.
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4.1.6 Health-related quality of life: The 15D and the EQ-5D
The 15D measure includes 15 questions, tapping 15 dimensions of HRQoL: mobility, vision,
hearing, breathing, sleeping, eating, speech, elimination, usual activities, mental
function, discomfort and symptoms, depression, distress, vitality and sexual activity
(Sintonen 1994; Sintonen 1995; Sintonen 2001). Each dimension has five grades of severity,
and so the 15D defines a vast number of health states. The 15D can be used as a single
index score measure or as a profile. In this study, to calculate the 15D utility index, we
have used valuations elicited from the Finnish population using the multi-attribute
utility method (Sintonen 1995). The 15D values range between 1 (full health) and 0 (dead).
Changes of over 0.02 - 0.03 points on the 15D scale are considered minimally clinically
important (Sintonen 1994; Sintonen 2001), as people are likely to consider themselves
feeling better or worse after changes of this magnitude. Study III also included a 15D
profile, which shows how individual dimensions of HRQoL are affected. In calculating the
profile, the above mentioned preference-based scoring system was used to scale all
dimensions between 0 and 1, thus making the losses on different domains comparable. The
15D compares favourably with similar instruments in most of the important properties
(Sintonen 1994; Sintonen 1995; Hawthorne, Richardson et al. 2001; Sintonen 2001; Stavem,
Bjornaes et al. 2001). The 15D was included in questionnaire 3. Subjects with 12 or more
completed 15D dimensions were included, and missing values were predicted with linear
regression analysis using the other 15D dimensions, with age and gender as independent
variables, as recommended by the author of the measure (Sintonen 1994). Six percent of
respondents had 1-3 dimensions imputed; of these, 85% had only one dimension missing. The
most common missing dimension was sexual functioning.
The EuroQoL EQ-5D measure (1990; Brooks 1996; Rabin and de Charro 2001) includes five
questions, tapping five dimensions of HRQoL: mobility, self-care, usual activities, pain
or discomfort and anxiety or depression. Each dimension is divided into three categories
of severity: no, moderate or extreme problems. Thus the EQ-5D defines 243 different health
states. It too can be converted into a single index score representing health utilities.
This study used the most commonly used tariff, the UK time-trade-off (TTO) values to
generate the EQ-5D utility index (Dolan, Gudex et al. 1996; Dolan 1997; Kind, Hardman et
al. 1999). The EQ-5D TTO-index values range from 1 (full health) to -0.59 (0=being dead).
There is no unequivocally agreed threshold for minimally clinically important change on
the EQ-5D, but thresholds averaging 0.07 points have been observed (Walters and Brazier
2005). The EQ-5D is among the most evaluated of HRQoL measures (Garratt, Schmidt et al.
2002). The EQ-5D and the 15D have been compared in a few studies, and demonstrated good
test-retest reliability and construct validity (Hawthorne, Richardson et al. 2001; Stavem,
Bjornaes et al. 2001). The EQ-5D was included in questionnaire 1, and only respondents
fully completing the instrument were included in the analysis; there is no established way
to reliably impute missing EQ-5D values.
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4.1.7 Subjective quality of life, health and mental well-being
Study IV also included measurements of global, subjective quality of life, self-rated
health (SRH) and mental well-being. Subjective QoL was measured by asking the respondents
to rate their current quality of life as a whole, for the last 30 days, on a scale from 0
(worst possible quality of life) to 10 (best possible quality of life). Self-rated general
health was measured similarly, asking the participants about their current health status
with a 10-point Likert scale anchored at worst possible health (0) and best possible
health (10). Mental well-being was measured with the 12-question version of the General
Health Questionnaire (GHQ-12)(Goldberg 1972; Goldberg, Gater et al. 1997). The scale has a
range between 0 and 12, with higher points indicating higher mental distress. GHQ is also
widely used as a screening instrument for mental disorders. Ideal cut-off points for
identifying mental disorders vary between populations, but generally fall between >1 and
>3 positive answers (Goldberg, Gater et al. 1997; Schmitz, Kruse et al. 1999; Holi,
Marttunen et al. 2003). Subjects with 9 or more completed GHQ-12 questions were included
in the analysis, and the GHQ sum score was calculated weighted to number of missing
responses.
4.2 Response rates
The original sample comprised 8028 persons, of whom 7977 were alive at the beginning of
the study. 6986 (88%) people were interviewed in their home or in an institution, and 6770
(85%) participated in either the health examination proper, or the home health
examination. 6681 (83%) of participants completed either the 15D or EQ-5D. 77% completed
the 15D and 77% completed the EQ-5D. Non-respondents were significantly older (average
58.8 years) than those who responded to either of the HRQoL questionnaires (average 52.3
years for EQ-5D, 52.5 years for 15D, P<0.001). GHQ-12 was available for 84.8%, SRH for
85.1% and QoL for 85.1% of the sample.
4.3 Statistical methods
All statistical analyses have been conducted using STATA 8 for Windows statistical
software (StataCorp 2003). Analyses used the survey procedures of STATA and took into
account the two-stage sampling design, oversampling of old people and non-response using
weights calibrated in Statistics Finland (Heistaro 2005). This was done to ensure the
prevalence of conditions and other rates given in this study match the true prevalence of
disorders in the Finnish population as closely as possible. Similarly, the regression
analyses included as many participants as possible. In practice this means that the
prevalence of disorders presented in the tables of this study can not always be directly
calculated from the number of cases presented. Also, as the different analyses included in
this study use data from slightly different combinations of instruments, the number of
participants in different analyses varies slightly.
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4.3.1 HRQoL, censoring and corner solutions
This study aimed to estimate the HRQoL losses associated with common chronic somatic
conditions, psychiatric disorders and alcohol consumption patterns. In addition to
presenting unadjusted data and background characteristics, regression modelling was used
to take into account sociodemographic factors and chronic conditions, as considered
appropriate in each study. Studies I and II adjusted for age, gender, education, income,
marital status and chronic conditions, as the aim was to estimate the individual
contribution of each condition or disorder. Due to the large number of conditions
included, interactions between variables were not explored. Study III included four
different regression models that added somatic and psychiatric conditions stepwise, in
order to investigate the importance of somatic and psychiatric comorbidity to the HRQoL
impact of psychiatric conditions. Study IV did not adjust for somatic conditions, as it
was hypothesised that there is a complex interaction between alcohol consumption,
abstaining, age and somatic and psychiatric disorders (alcohol consumption causes illness,
and illness influences alcohol consumption). Furthermore, Study IV investigated gender
separately using different categories of alcohol consumption, as the patterns of
consumption and effects of alcohol vary between genders.
All utility-based HRQoL measures are anchored to death (0) and perfect health (1).
However, the measures differ greatly in the actual distribution of the scores. In general
population studies, most HRQoL instruments have a large proportion of respondents
reporting perfect health, commonly interpreted as right-censored data. In Health 2000
data, this rate is 15% for 15D and 47% for EQ-5D. Thus we have used a Tobit regression
model for the regression analyses of HRQoL data (Tobin 1958; Austin, Escobar et al. 2000).
EQ-5D TTO index is statistically far more problematic than the 15D, as in addition to the
high rate of censoring the scale is not continuous but includes a gap between 1 and 0.88
However, this choice is not entirely unproblematic. The rate of people receiving perfect
scores (1) on HRQoL is commonly seen as censoring rate, i.e. it is assumed that there is
true variation of HRQoL above 1 but this is not captured by the measures. This is
theoretically acceptable on the one hand, because it is unlikely that the health of a
large group would be exactly similar, and that the health of this population could not be
improved. On the other hand however, it is also possible that people will at a certain
point simply stop trading length of life or possibility of death for improved health; this
would be more appropriately called a "corner solution" rather than "censoring" (Wooldridge
2002). In both cases, however, a further problem is that Tobit regression, like ordinary
linear regression, is based on normal distribution of residuals.
Another alternative proposed for censored data is the censored least absolute deviations
(CLAD) model (Powell 1984; Austin 2002). CLAD models, incorporating weights and
clustering, can be estimated in STATA using a user-written macro. The question whether to
use Tobit or CLAD models cannot be answered purely on statistical grounds, however,
because the models estimate different things (Wooldridge 2002). The Tobit (and ordinary
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least squares) models estimate the changes of the mean, whereas CLAD estimates changes of
the median. This presents a problem, when trying to estimate QALYs, because they should
reflect the strength of each individual’s preferences. It can be argued (Dolan 2000;
Clarke, Gray et al. 2002), but we have assumed that the use of the mean is more
appropriate in the QALY context.
Equally important is to decide which marginal effects one is interested in. Four different
marginal effects can be estimated for the Tobit model. The beta coefficient of the Tobit
describes the changes of the latent (unobserved) variable (e.g. the true HRQoL which
expands over 1). Other possible estimates are changes on the unconditional expected value
of the dependent variable (e.g. the expected changes on the measured HRQoL scores, as done
in this study), changes on probability of being uncensored and changes in the conditional
expected value of the dependent variable (McDonald and Moffitt 1980; Cong 2000).
In practise, many surveys still use ordinary least squares (OLS) regression even with
EQ-5D (Burström, Johannesson et al. 2001; Burström, Johannesson et al. 2001; Lubetkin, Jia
et al. 2005). With the high censoring rates of EQ-5D, this can cause significant bias
(Austin, Escobar et al. 2000). In Study I CLAD and Tobit models were compared for
analysing HRQoL data. It was concluded that marginal effects after Tobit models can be
used when QALY estimates are needed for both 15D and EQ-5D, but that the 15D estimates are
likely to be more reliable than the EQ-5D estimates. Thus marginal effects after Tobit
regression have been used in Studies II-IV, emphasising 15D results.
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5. Results
5.1 The individual-level HRQoL impact of major chronic conditions
This study investigated how 29 common chronic conditions associated with individual-level
HRQoL losses. This was done separately for each condition (Study I), and by diagnostic
categories and age-groups (Study II).
Chronic conditions were found to be common: 76% of participants had at least one of the
conditions included in the study, and 55% had two or more conditions. Number of conditions
increased with age from average of 1.1 conditions at ages between 30 and 45 years to an
average 4.0 conditions at ages 75 or over. Prevalence of individual conditions is reported
in Table 2 and for groups of conditions in Table 3. The only group of conditions that did
not increase in prevalence by age was psychiatric conditions.
Considering the unadjusted HRQoL scores reported, people with Parkinson’s disease, heart
failure, macular degeneration and stroke reported the lowest scores on both 15D and EQ-5D.
When disorders were grouped and investigated by age-groups, people diagnosed with
psychiatric disorders had the lowest HRQoL scores in all age-groups as measured by 15D. On
EQ-5D, people with vision problems, psychiatric problems and musculoskeletal problems had
the lowest EQ-5D scores at younger ages, whereas those with neurological disorders had the
lowest scores in the oldest age-group.
Figure 1 shows the HRQoL loss associated with each condition on both measures, sorted by
condition severity on 15D, when all background variables and other chronic conditions were
adjusted for. In the fully controlled models, Parkinson’s disease was still the most
disabling condition on both measures. On 15D, depressive disorders, psychosis and anxiety
disorders were the most severe conditions after Parkinson’s. On EQ-5D, these were anxiety
disorders, arthrosis of the hip and knee and depressive disorders. Only four of the 29
chronic conditions did not have a statistically significant (p<0.05) association with
HRQoL on either 15D or EQ-5D.
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Figure 1. Severity (HRQoL losses associated with chronic conditions, left) and public
health burden (annual QALY losses associated with morbidity, per 1000 people, right).
Adjusted for age, gender, education, income, marital status and other conditions, 
with 95% confidence intervals.
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When investigating the conditions in groups (Study II) adjusting for background variables
and other groups of conditions, psychiatric disorders were associated with the largest
losses of HRQoL in all agegroups on 15D. On the EQ-5D, psychiatric and musculoskeletal
disorders were associated with the largest impact on HRQoL up to 75 years of age, after
which neurological disorders were more severe (Table 3).
Investigating the interactions between the severity of HRQoL impact for groups of
conditions and age, only musculoskeletal and hearing problems displayed a statistically
significant age-interaction on both measures. When individual conditions were
investigated, only loss of hearing had statistically significant age interaction on both
measures; loss of hearing had less impact at 65-74 years than at other ages.
Table 3. Prevalence of conditions. Marginal effects of conditions on health utility (SE),
measured with 15D, by age-groups, adjusted for socioeconomic factors and other conditions.
The results of the likelihood ratio test for age-condition interaction.
Condition                       All (30- years)    30 - 44 years      45 - 54 years      55 - 64 years      65 - 74 years      75- years          Age-
                                                                                                                                                     condition
                                                                                                                                                     inter-
                                                                                                                                                     action
                                                                                                                                                     p-value
   Number of chronic conditions     2.1                1.1                1.7                2.5                3.2                4.0                
   Pulmonary disorders             12.8   %            8.4   %           10.9   %           14.2   %           20.2   %           18.6   %
      15D loss (SE)                -0.029 (0.003)***   -0.014 (0.005)**   -0.027 (0.007)***   -0.027 (0.008)***   -0.041 (0.009)***   -0.038 (0.011)***   0.047
   Cardiovascular disorders        33.0   %           14.8   %           29.5   %           44.3   %           52.1   %           53.7   %
      15D loss (SE)                -0.020 (0.002)***   -0.006 (0.004)     -0.011 (0.004)**   -0.018 (0.004)***   -0.022 (0.006)***   -0.015 (0.010)      0.153
   Musculoskeletal disorders       30.6   %           14.9   %           26.6   %           41.2   %           46.6   %           50.3   %
      15D loss (SE)                -0.036 (0.002)***   -0.022 (0.004)***   -0.038 (0.004)***   -0.036 (0.005)***   -0.032 (0.007)***   -0.019 (0.009)*     0.013
   Hearing problems                22.5   %           10.1   %           18.3   %           29.7   %           35.6   %           42.2   %
      15D loss (SE)                -0.018 (0.002)***   -0.010 (0.005)*    -0.012 (0.004)**   -0.014 (0.005)**   0.004 (0.006)      -0.020 (0.008)*     0.027
   Vision problems                  8.3   %            0.7   %            3.0   %            7.5   %           18.5   %           32.7   %
      15D loss (SE)                -0.044 (0.005)***   -0.017 (0.011)     -0.035 (0.013)**   -0.025 (0.008)**   -0.023 (0.008)**   -0.029 (0.010)**    0.873
   Psychiatric disorders           11.5   %           14.0   %           14.1   %           11.6   %            6.2   %            3.7   %
      15D loss (SE)                -0.048 (0.003)***   -0.051 (0.004)***   -0.063 (0.006)**   -0.047 (0.009)***   -0.059 (0.014)***   -0.054 (0.017)**    0.414
   Neurological disorders          10.6   %            8.4   %           8.7    %           12.0   %           12.0   %           17.2   %
      15D loss (SE)                -0.016 (0.003)***   -0.014 (0.005)**   -0.005 (0.005)     -0.021 (0.008)**   -0.015 (0.010)     -0.035 (0.011)**    0.108
   Disabilities by accident        13.5   %            9.5   %           12.3   %           16.2   %           16.6 %             20.5   %
      15D loss (SE)                -0.024 (0.004)***   -0.024 (0.005)***   -0.008 (0.006)     -0.019 (0.006)**   -0.025 (0.009)**   -0.041 (0.011)***   0.005
   Other disorders                 27.4   %           14.8   %           22.1   %           32.2   %           40.0 %             55.1   %
      15D loss (SE)                -0.030 (0.002)***   -0.017 (0.004)***   -0.022 (0.004)***   -0.032 (0.005)***   -0.026 (0.005)***   -0.032 (0.009)***   0.141
*  p<0.05, ** p<0.01, *** p<0.001
40
5.2 The public health impact of chronic conditions
The public health impact of the 29 included chronic conditions was estimated by calculating
the QALY losses associated with morbidity, separately for individual conditions and groups
of conditions at different ages.
The QALY losses of individual conditions (Study I) are presented in Figure 1. Measured
with 15D, the largest QALY losses were associated with depression, urinary incontinence
and arthrosis of hip or knee. On EQ-5D, arthrosis of the hip and knee were associated with
the largest loss of QALYs. Next, with practically equal impact came other arthrosis, back
problems, depression and disabilities caused by accidents.
When the conditions were grouped (Study II, prevalence reported in table 3),
musculoskeletal disorders were associated with 23% (15D) and 37% (EQ-5D) of the total
annual QALY losses due to morbidity found in the study. Psychiatric disorders came second
with 12% and 11% of the total, as measured with 15D and EQ-5D, respectively.
The impact of different groups of conditions on lost QALYs varied greatly by age. The
absolute amount of lost QALYs per 100 000 persons on 15D and the relative proportions
attributable to different conditions are presented in Figure 2. Psychiatric disorders were
the largest cause of lost QALYs due to morbidity at ages under 45, representing 29%
(EQ-5D) and 37% (15D) of the total for these ages. However, as the amount of QALYs lost
associated with other disorders increased by age, psychiatric disorders were the only
group of conditions where not only the relative but also the absolute amount of QALYs lost
(per constant number of people) actually decreased in the oldest age-groups.
Musculoskeletal disorders were associated with high loss of QALYs across all age groups,
whereas the importance of vision problems increased dramatically with age.
In sum, although there were some statistically significant variations in the severity of
conditions by age, the differences in prevalence were far greater and accounted for a
majority of the differences in the public health impact of different conditions at
different ages.
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Figure 2. Relative and absolute QALY losses associated with morbidity, separately for
age-groups and groups of conditions.
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5.3 Ageing of the population and QALYs lost to chronic conditions
The Finnish population is ageing, so that according to official predictions the number of
people aged over 64 will increase by around 70% between years 2005 and 2040, while the
number of people aged over 30 will increase by 9% and the total population will grow only
marginally.
The absolute yearly QALY losses associated with morbidity in Finland are presented in
Figure 3 for 2005 population, and were predicted to years 2020 and 2040 using official
predictions of Statistics Finland. If morbidity remains constant (i.e. the severity and
prevalence of conditions by age remain similar) the absolute annual loss of QALYs due to
morbidity will increase by 23% up to the year 2040 due to ageing of the population. The
changes in relative importance of different conditions appear, however, modest.
5.4 The HRQoL and QALY losses associated with depressive and
anxiety disorders and alcohol dependence
It was investigated how different depressive (major depressive disorder and dysthymia) and
anxiety disorders (panic disorder, agoraphobia, social phobia and generalized anxiety
disorder) and alcohol dependence associate with HRQoL at the individual and population
levels. Furthermore, the effect of comorbidity between these psychiatric conditions and
the dimensions of HRQoL that were affected was investigated. The prevalence of conditions,
rates of comorbidity and unadjusted HRQoL scores are presented in Table 4.
The average unadjusted 15D (EQ-5D) score for the population was 0.91 (0.83), and 0.87
(0.72) for people with any psychiatric diagnosis. The lowest scores were reported by
people with comorbid forms of dysthymia, GAD, agoraphobia and social phobia.
The magnitude of the HRQoL losses was further estimated with four different models. First,
controlling for sociodemographic factors (age, gender, education, living arrangements and
income), second, controlling for sociodemographics and somatic comorbidity and third,
controlling for sociodemographics, somatic conditions and psychiatric comorbidity.
Fourthly, pure forms of conditions were investigated separately, controlling for
sociodemographics and somatic comorbidity. The results are presented in Figure 4 for 15D.
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Figure 3. Absolute annual loss of QALYs associated with morbidity at different ages in
Finland in 2005 and predictions for 2020 and 2040. 
2020
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Table 4. Prevalence of psychiatric disorders, psychiatric comorbidity and 
unadjusted 15D and EQ-5D scores of respondents.
                                Prevalence %       Proportion with    Mean 15D score     Mean EQ-5D score
                                   (N)*               psychiatric        (SE)               (SE)
                                                      comorbidity
   Group of respondents
   Study population                 -   (6005)            12.2**           0.910 (0.001)      0.835 (0.003)
   Disorder
   Any depressive disorder          6.5  (392)            39.2             0.840 (0.005)      0.729 (0.014)
   Only depressive disorder         4.4  (272)            11.7             0.867 (0.006)      0.789 (0.013)
   Any anxiety disorder             4.1  (242)            55.6             0.832 (0.007)      0.687 (0.018)
   Only anxiety disorder            2.1  (127)            14.1             0.879 (0.008)      0.750 (0.021)
   Alcohol dependence               3.9  (223)            23.3             0.893 (0.007)      0.829 (0.013)
   Pure alcohol dependence          3.0  (173)            -                0.915 (0.006)      0.866 (0.012)
   MDD                              4.9  (298)            38.4             0.859 (0.006)      0.764 (0.014)
   Pure MDD                         3.1  (192)            -                0.889 (0.006)      0.833 (0.011)
   Dysthymia                        2.4  (147)            63.0             0.766 (0.009)      0.583 (0.024)
   Pure dysthymia                   0.9   (57)            -                0.810 (0.014)      0.687 (0.033)
   Panic disorder                   1.9  (114)            48.7             0.859 (0.009)      0.765 (0.022)
   Pure panic disorder              1.1   (59)            -                0.908 (0.009)      0.821 (0.028)
   Social phobia                    1.0   (60)            77.1             0.801 (0.016)      0.659 (0.034)
   Pure social phobia               0.2   (14)            -                0.891 (0.019)      0.729 (0.052)
   Agoraphobia                      1.0   (62)            84.3             0.781 (0.016)      0.622 (0.036)
   Pure agoraphobia                 0.2   (13)            -                0.818 (0.016)      0.636 (0.065)
   GAD                              1.3   (75)            68.3             0.783 (0.019)      0.589 (0.038)
   Pure GAD                         0.4   (24)            -                0.864 (0.018)      0.654 (0.046)
*  Numbers are based on participants with complete M-CIDI information. Percentages are adjusted for the survey design.
** Proportion with any M-CIDI diagnosis.
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Figure 4. HRQoL losses associated with psychiatric conditions, controlling for
socioeconomic factors, somatic comorbidity, and psychiatric comorbidity and
in pure forms of conditions, with 95% confidence intervals.
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After controlling for sociodemographic variables and somatic conditions, the largest HRQoL
losses were associated with dysthymia, agoraphobia, GAD and SP. Alcohol dependence had
lowest impact, with panic disorder and MDD in between. Several disorders appeared more
severe than the most severe somatic condition identified in Study I, Parkinson’s disease,
which was associated with a loss of -0.07 points on 15D.
Figure 4 also shows how adjusting for psychiatric comorbidity decreased the impact of
individual disorders clearly. These decreases were relatively largest on anxiety
disorders, especially agoraphobia, and smallest on alcohol dependence. After controlling
for other psychiatric disorders, the largest losses of HRQoL were associated with
dysthymia, SP and GAD. Considering pure forms of disorders, i.e. only those respondents
receiving one M-CIDI diagnosis, the picture was similar: the largest HRQoL losses were
found for dysthymia, SP and GAD
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The  15D HRQoL  profiles  for  alcohol  dependence, anxiety- and depressive  disorders  are
presented in Figure 5. The HRQoL profiles of alcohol dependence, anxiety- and depressive
disorders were strikingly similar, only the magnitude of the effect of alcohol dependence
is smaller on all dimensions. Equally, the dimensions of HRQoL most affected were the same
for all disorders: depression, distress, vitality and sleeping. The decrease of HRQoL was
widespread: a statistically significant decrease of HRQoL was found on most of the 15
dimensions covered by the 15D.
Figure 5. The 15D dimensions of HRQoL affected by alcohol dependence, depressive and
anxiety disorders, controlling for age and gender.
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47
5.5 Alcohol consumption, HRQoL and other measures of well-being
The association between HRQoL, subjective QoL, self-rated health (SRH), mental distress
(GHQ-12) and alcohol consumption was investigated in Study IV. Alcohol consumption
categories, aiming at equally sized deciles, are presented in Table 5. Women clearly
consumed less alcohol and were more often abstainers than men.
    Table 5. Alcohol consumption categories, for participants aged 30-64 years.
Men                            N    Mean alcohol   Women                          N    Mean alcohol
                                       consumption                                        consumption
                                       g/week                                             g/week
   All men                        2380     140        All Women                      2603      41
   0 g/wk  ’Other abstainers’      270       0        0 g/wk  ’Other abstainers’      735       0
   0 g/wk  ’Former drinkers’       147       0        0 g/wk  ’Former drinkers’        90       0
   1-7     g/wk                     94       6        1-7     g/wk                    237       5
   8-24    g/wk                    234      18        8-16    g/wk                    281      13
   25-49   g/wk                    241      38        17-24   g/wk                    221      21
   50-73   g/wk                    227      63        25-39   g/wk                    273      33
   74-105  g/wk                    239      90        40-61   g/wk                    248      50
   106-146 g/wk                    217     126        62-117  g/wk                    263      83
   147-228 g/wk                    238     185        118-173 g/wk                    130     142
   229-348 g/wk                    237     276        >173    g/wk                    125     289
   >348    g/wk                    236     624
The results of regression models investigating the association of alcohol consumption and
the different outcomes are presented in figures 6 to 13, separately for both genders and
each of the measures: 15D, subjective QoL, SRH and GHQ-12. Each graph presents two models,
the first controlling for age, and the second controlling age, education, income and
living arrangements.
For HRQoL, former drinkers scored worst on 15D on both raw scores and also when
sociodemographic variables were controlled for. Only the most heavily drinking groups
(women drinking an average of 289g (24 drinks) and men an average of 624g (52 drinks) per
week) got statistically significantly lower 15D scores than abstainers who were not former
drinkers. Moderate drinkers HRQoL scores were better than other abstainers, but these
differences were clinically unimportant and also not statistically significant in the
fully controlled models.
For other measures of well-being, women who were former drinkers scored worst on
subjective QoL and SRH. Moderate drinkers had statistically significantly better SRH than
other abstainers, but this was not observed on subjective QoL or GHQ-12. In contrast, the
highest drinking groups had statistically significantly poorer subjective QoL and higher
mental distress than other abstainers, but this was not found on SRH. For men, all three
measures yielded similar results: former drinkers and the men who drank over 229g/week had
statistically significantly worse scores than other abstainers. In the fully controlled
models, other abstainers actually had the best scores, and there was no trend for a
J-shaped association between well-being and drinking.
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Figure 6. 15D Health-related quality of life differences (scale 0-1) associated with
different alcohol consumption levels for women. Controlling for age, or age,    
education, income and living arrangements. 95% confidence intervals.
Figure 7. Subjective quality of life differences (scale 0-10) associated with     
different alcohol consumption levels for women. Controlling for age, or age,    
education, income and living arrangements. 95% confidence intervals.
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Figure 8. Self-rated health differences (scale 0-10) associated with different alcohol
consumption levels for women. Controlling for age, or age, education, income    
and living arrangements. 95% confidence intervals.
Figure 9. Mental distress differences (GHQ-12, scale 0-12 with higher scores   
indicating higher distress) associated with different alcohol consumption levels for   
women. Controlling for age, or age, education, income and living arrangements. 95%    
confidence intervals.
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Figure 10. 15D Health-related quality of life differences (scale 0-1) associated with   
different alcohol consumption levels for men. Controlling for age, or age, education,   
income and living arrangements. 95% confidence intervals. 
Figure 11. Subjective quality of life differences (scale 0-10) associated with    
different alcohol consumption levels for men. Controlling for age, or age, education,     
income and living arrangements. 95% confidence intervals.
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Figure 12. Self-rated health differences (scale 0-10) associated with different    
alcohol consumption levels for men. Controlling for age, or age, education, income   
and living arrangements. 95% confidence intervals.
Figure 13. Mental distress differences (GHQ-12, scale 0-12 with higher scores    
indicating higher distress) associated with different alcohol consumption levels for   
men. Controlling for age, or age, education, income and living arrangements. 95%    
confidence intervals.
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6. Discussion
The  previous  time  that  comparably  valid and  comprehensive health data was collected in
Finland was the Mini-Finland Health Survey between 1978 and 1980. It did not include HRQoL
measurement. Our study is based on the idea that knowledge of the HRQoL of the population
and the loss of HRQoL associated with common chronic conditions is useful for rational
health care and public health policy. This information may be used to identify
interventions and public health programmes that could produce the largest public health
improvements by showing how many QALYs could be saved by eliminating certain chronic
conditions. Population-based reference values may also be used to gauge the extent to
which populations in condition-specific cost-effectiveness studies or quality-improvement
programmes are comparable to national averages (Sullivan, Lawrence et al. 2005).
Despite the recognised importance of measuring HRQoL in different diseases and in
representative general population surveys, there are very few general population surveys
using utility-based HRQoL measures and including several conditions. Despite the
recognised public health burden of psychiatric disorders and the known challenges in
diagnosing them in surveys, very few HRQoL surveys have included reliable diagnosis of
psychiatric disorders. Despite the lack of a golden standard in HRQoL measurement and the
wide variety of methods used to measure HRQoL, it has been rare to use more than one HRQoL
measure simultaneously. This study aimed to overcome these weaknesses by measuring the
utility-based HRQoL using two established instruments in a representative, general
population sample of Finns using a thorough list of somatic conditions, reliable
diagnostics of psychiatric disorders and alcohol consumption.
6.1 Principal findings
Investigating the HRQoL impact associated with major chronic conditions (Study 1) showed
that at the individual level the most serious conditions on 15D were Parkinson’s disease,
anxiety disorders, depressive disorders and psychosis. EQ-5D emphasised the severity of
musculoskeletal conditions, especially arthrosis. At the population level, the most severe
conditions (largest losses of annual QALYs associated with morbidity on 15D) were
depression, urinary incontinence and arthrosis of hip and knee.
Considering disorders in groups (Study II), the largest public health burden (loss of
annual QALYs associated with morbidity on 15D) was found for musculoskeletal and
psychiatric disorders, which were associated with 23% and 12% of the total disease burden
identified in this study. Psychiatric disorders were associated with the largest health
burden at ages 30 to 44, representing 37% of the total QALYs lost identified.
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Investigating changes over age revealed that although the severity of some conditions
varied with age, this variation was of little significance in comparison with the large
variation in prevalence. The loss of HRQoL attributable to chronic conditions was found to
increase fourfold when comparing people aged 30-44 to people aged over 75 years. The
ageing of the Finnish population was estimated to lead to about 25% increase in the QALYs
lost attributable to morbidity from chronic conditions up to year 2040, assuming unchanged
morbidity patterns.
A detailed comparison of different anxiety, depressive and alcohol use disorders (Study
III) showed that the commonly chronic conditions dysthymia, agoraphobia, GAD and SP were
associated with the largest losses of HRQoL on individual level.
The HRQoL losses associated with dysthymia and GAD were larger than those associated with
any of the somatic conditions investigated in Study I. This was partly explained by the
finding that scores were statistically significantly reduced on most dimensions of HRQoL.
Considering the public health impact of psychiatric conditions, the QALY loss due to
morbidity associated with anxiety disorders was about a half of those associated with
depressive disorders, and alcohol dependence was associated with about half of the burden
of anxiety disorders.
Studying the association between alcohol consumption and HRQoL (Study IV) revealed that
abstainers who were former drinkers got clearly worse scores in comparison to other
abstainers, scoring worse than or equal to persons belonging to the decile that consumed
most alcohol. This highlighted the importance of not investigating abstainers as one
homogenous group, as this is likely to produce flawed estimates of the effects of
abstaining on health. Considering moderate drinking, no statistically significant or
clinically important associations between 15D and moderate alcohol consumption were
observed after controlling for sociodemographic factors.
6.2 Comparison to previous studies
6.2.1 Comparison of severity of psychiatric and somatic conditions
This study identified Parkinson’s disease, depressive disorder, psychosis and anxiety
disorder as the four most severe disorders on 15D, i.e. showed that common psychiatric
disorders have, on average, more severe effects on HRQoL than chronic somatic conditions.
Study III showed that especially poor HRQoL was reported by people with dysthymia, GAD,
SP and agoraphobia, which are typically chronic conditions (Yonkers, Bruce et al. 2003;
Klein, Shankman et al. 2007). For example, the unadjusted HRQoL scores of patients
suffering from dysthymia and GAD were below 0.8 on 15D and below 0.6 on EQ-5D -
comparable to scores reported by people 20 years older and suffering from Parkinson’s
disease or heart failure.
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Direct comparison to previous studies is however limited, as none of the representative
general population surveys using utility-based HRQoL measures (presented in Table 1)
included reliable diagnostics of several psychiatric disorders. Some surveys have relied
on self-report (Fryback, Dasbach et al. 1993; Sullivan, Lawrence et al. 2005), used GHQ as
measure of psychiatric distress (Burström, Johannesson et al. 2001) or depression
screening questions (Johnson and Pickard 2000). Two studies used different sets of CIDI
items to diagnose depression, but did not include any other psychiatric disorders (Wells
and Sherbourne 1999; Manuel, Schultz et al. 2002).
However, the substantial impact of psychiatric disorders, particularly depression, in
comparison to somatic conditions has been evident even when these varying measures were
used. For example, a Swedish study that used GHQ-12 as an indicator for mental distress
(with a low cut-off score of 1/2 and consequently high (21%) prevalence of distress) found
that mental distress was associated with a lower adjusted EQ-5D score (-0.125) than any
other of the seven included conditions (Burström, Johannesson et al. 2001). A US study
using self-reported affective disorders (with a prevalence of 1%) found a smaller impact
on EQ-5D (-0.07) (Sullivan, Lawrence et al. 2005), while another US study using QWB found
-0.08 utilities for self-reported depression (prevalence of 4.6%) (Fryback, Dasbach et al.
1993). In both studies, depression was among the most severe of conditions, when at least
age was adjusted for. Studies from Sweden and the USA, both using direct valuation
techniques, found depression to be clearly the most severe condition, with twice the
impact compared to the next severe of the circa 10 chronic conditions included. The
utility losses associated with depression (measured with TTO) were almost identical in
these studies: -0.09 in Sweden (Isacson, Bingefors et al. 2005) and -0.08 in the USA
(Wells and Sherbourne 1999).
Considering the public health burden of diseases, the results of this study could be
compared to studies using a related methodology, namely those measuring years lived with
disability (YLD); this approach is used, for example, in the WHO burden of disease studies
(Murray and Lopez 1996). In these studies, universal disability weights for each disorder
are estimated by medical experts and combined with prevalence estimates. This contrasts
with the method used in this study that measured the disability reported by the
individuals directly. Also the included conditions always vary, so all comparisons must be
treated as tentative. WHO has estimated that over 20 percent of all YLD globally can be
attributed to psychiatric conditions (WHO 2001). In accordance with the results of this
study, the WHO estimated psychiatric disorders to have the largest impact on YLD at ages
under 60, although the proportion of disability attributed to psychiatric disorders by the
WHO was even larger, around 50% at 30-44 years in Western Europe (WHO 2004), than in our
study. The proportion of YLD explained by musculoskeletal disorders was much smaller in
the WHO study or in a comparable Dutch study (Melse, Essink-Bot et al. 2000), and
especially so at young ages and in comparison to our EQ-5D results. Also among Australians
aged 35-54, psychiatric disorders accounted for over 30% and musculoskeletal disorders
over 10% of YLD (Mathers, Vos et al. 1999). The Dutch study involved 48 conditions and
listed the six largest causes of YLD as anxiety disorders, visual impairments, alcohol
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dependence, depression, chronic lung diseases and hearing impairments (Melse, Essink-Bot
et al. 2000). In general, the 15D results of this study were more in line with the WHO and
other previous YLD results, than the EQ-5D results.
6.2.2 Comparing different psychiatric disorders
It is well established that affective and anxiety disorders cause significant distress,
lowered HRQoL, and disability on several domains of life. The impact of alcohol use
disorders generally appears smaller (Ormel, VonKorff et al. 1994; Bijl and Ravelli 2000;
Alonso, Angermeyer et al. 2004; Sareen, Stein et al. 2005). The results of this study
concur with this general picture: relatively comparable severity of anxiety and depressive
disorders, and clearly smaller severity for alcohol use disorders. In a more detailed
comparison, the typically chronic disorders dysthymia, agoraphobia, GAD and SP were found
to be associated with larger losses of individual HRQoL than MDD, panic disorder or
alcohol dependence.
Concerning previous studies, most mental health HRQoL surveys have used SF-36 (Ware and
Sherbourne 1992) and related instruments. Only two of the studies reviewed in Table 1
included several of the psychiatric disorders diagnosed in the present study. A US survey
(Sullivan, Lawrence et al. 2005) found that self-reported "affective disorders" were
associated with larger health utility loss (loss of 0.07 on EQ-5D) than "anxiety,
somatoform, dissociative or personality disorders" (-0.04). "Alcohol-related disorders"
did not have a statistically significant association with the EQ-5D. A Swedish postal
survey (Isacson, Bingefors et al. 2005) came to identical conclusions using a TTO
exercise: 0.09 lost utilities for depression, and 0.045 lost for anxiety. The latter study
controlled for the other conditions, whereas the former controlled for the number of
conditions. A large US study of managed care patients (Wells and Sherbourne 1999) using
both SG and TTO methods found that after adjustment for somatic conditions and
socioeconomic variables, probable 12-month depression was associated with loss of 0.079
health utilities on TTO and 0.036 on SG. The results are well in line with our findings
for depression (-0.09 for EQ-5D and -0.06 for 15D). Equally in line with the findings of
this study was the US finding that dysthymia alone was clearly more severe (-0.08 on TTO)
than MDD alone (-0.05). However, in contrast to US results, this study found anxiety
disorders to be more severe than or equal to depression (-0.11 on EQ-5D, -0.05 on 15D).
This difference may be due to differences in diagnostics: the present study used
structured diagnostic interview, whereas the two other studies were based on self-report
which is mirrored in widely varying prevalence of conditions. More generally, this
highlights the importance of using structured diagnostic methods when estimating the
burden of psychiatric disorders.
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6.2.3 Alcohol consumption
Abstainers who were former drinkers were found to be quite different from other
abstainers. Former drinkers got worse scores on all measures used, and the HRQoL scores of
former drinkers were statistically significantly and clinically importantly below other
abstainers. Positive associations between moderate alcohol use and SRH were observed for
women, but this was not found for other measures, or for men, when sociodemographic
variables were controlled for. Although there was a trend for improved HRQoL for moderate
drinkers, this was neither statistically significant nor clinically important. Heavy
drinkers showed a clear trend for worse health and well-being in comparison to moderate
drinkers, although not all comparisons were statistically significant. Still, the negative
impacts on HRQoL associated with heavy drinking could be considered relatively small, as
it was below the 0.03 level of minimal clinical importance, and clearly lower than that
found for common psychiatric conditions (as discussed above).
The author is not aware of previous surveys investigating alcohol consumption and
utility-based HRQoL in the general population, and even clinical studies using
utility-based HRQoL measures appear rare; a recent review on quality of life and
alcoholism found 36 studies using 12 different QoL-related measures, but only one clinical
study examined health utility (Donovan, Mattson et al. 2005). Clinical studies report far
worse results for alcohol users than population studies (Foster, Powell et al. 1999;
Foster, Peters et al. 2002) and can not be used to estimate average population level
impact of alcohol use. A cohort study investigating 31-year old Finns included alcohol
consumption and the 15D score; increasing alcohol consumption was associated with lower
15D score, but no J-shaped association was found (Häkkinen, Järvelin et al. 2006).
Comparisons to surveys using non-utility HRQoL instruments (typically the SF-36) can be
made, albeit with caution. Some studies using SF-36 have found former drinkers to score
worse than other abstainers and moderate drinkers better than abstainers (Saito, Okamura
et al. 2005; Stranges, Notaro et al. 2006) but there are also opposing results (van Dijk,
Toet et al. 2004). The differences in results may be due to differing populations,
response rates and classification of abstainers. Interestingly, however, none of these
surveys found heavy drinkers to have lowered HRQoL as did this study.
Considering other measures than HRQoL, the improved health and well-being of moderate
drinkers has been reported on several other instruments. A recent review on moderate
drinking, mental health and quality of life (El-Guebaly 2007) identified five surveys
investigating self-rated health and three investigating general mental health. Most of
these observed beneficial effects associated with moderate drinking. Although most did not
control for former drinkers (San Jose, van de Mheen et al. 1999; Guallar-Castillon,
Rodriguez-Artalejo et al. 2001; Wang, Smith et al. 2006), some did and still found
moderate drinkers to have better SRH than abstainers (Poikolainen, Vartiainen et al. 1996;
Power, Rodgers et al. 1998; French and Zavala 2007). Interestingly, only the previous
Finnish study (Poikolainen, Vartiainen et al. 1996) found former drinkers to be different
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from other abstainers. Of the studies that have investigated life satisfaction (LS), a
related concept to subjective QoL, or used GHQ (Hingson, Scotch et al. 1981; Roberts,
Brunner et al. 1995; Koivumaa-Honkanen, Honkanen et al. 2000) most found moderate
drinkers to have better well-being. However, this association mostly disappeared if
sociodemographic factors were controlled for, and none of these studies separated former
drinkers from other abstainers.
Although not statistically significant, this study still revealed a J-shaped trend
suggesting better HRQoL for moderate drinkers in comparison to abstainers and heavy
drinkers. However, the magnitude of improved HRQoL found for moderate alcohol users in
this study could be considered negligible, as the highest point-estimate was 0.007 on 15D,
clearly below the minimum limit for clinical importance, 0.03. The most consistent results
supporting J-shaped benefits for moderate drinkers come from mortality studies (Gmel,
Gutjahr et al. 2003; Di Castelnuovo, Costanzo et al. 2006; Rimm and Moats 2007) and those
investigating a dichotomous measure or SRH (Poikolainen, Vartiainen et al. 1996; French
and Zavala 2007). However, it is possible that although odds of poor SRH or premature
death are in a J-shaped relation to alcohol consumption, the HRQoL gains of moderate
alcohol consumption are clinically insignificant. Theoretically, this would not be
surprising, given that the health benefits of moderate alcohol consumption appear related
to cardiovascular diseases (CVD) (Rimm and Moats 2007). The health burden of CVD consists
more of premature mortality and less of functional limitations and loss of HRQoL during
lifetime (Manuel, Schultz et al. 2002). For example, people may be aware of having health
problems like poor lipid profile, but this would not be expected to greatly influence the
experienced HRQoL as long as there are no functional limitations. Thus, it is possible
that the positive health effects of alcohol that appear via CVD may not be fully captured
by HRQoL measurement. This suggests that mortality may be a sufficient metric for
capturing most of the possible health impact of moderate alcohol use.
6.2.4 Age and the HRQoL impact of conditions
Both age and chronic conditions decrease HRQoL (Fryback, Dasbach et al. 1993; Alonso,
Ferrer et al. 2004). The physical components of HRQoL are more strongly related to age and
somatic conditions than the mental health components; some studies have even found mental
components of HRQoL to improve with age (Singer, Hopman et al. 1999; Michelson, Bolund et
al. 2000; Sprangers, de Regt et al. 2000). Positive associations between disease duration
and mental health have also been observed (Singer, Hopman et al. 1999). Such findings have
been interpreted to suggest that a psychological adjustment process enables people to
maintain positive mental health despite physical disabilities due to somatic conditions
and old age. As was also apparent also in this study, chronic somatic conditions typically
affect older people, whereas common mental disorders appear at much younger age. This
highlights the importance of adjusting for age when comparing the HRQoL losses of
psychiatric disorders to most somatic disorders. For example, a Canadian study including
20 chronic conditions noted that depression was the only condition where age-adjusted HUI
scores were lower than raw scores (Manuel, Schultz et al. 2002).
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Previous studies have shown conflicting results regarding whether the individual severity
of conditions on HRQoL varies by age (Fryback, Dasbach et al. 1993; Schultz and Kopec
2003). This study helps explain these differing results, because although some
statistically significant differences in the severity of conditions at different ages were
found, these were very small in comparison to the differences in prevalence. An
overwhelming majority of differences in lost QALYs associated with morbidity at different
ages was due to varying prevalence of conditions. Thus, little support was found for
significant, individual adaptive processes that would cause the same conditions to have
different impact on HRQoL at different ages. However, it is of course possible that the
decline in prevalence of psychiatric disorders by age is due to these hypothesized
psychological or social processes that also increase mental well-being and psychological
components of HRQoL with age, relative to physical components.
6.3 Strengths and weaknesses
6.3.1 The survey
The most important strength of this study is that it reliably estimated the burden of the
major chronic conditions as they occur in the population. This is an advantage over the
YLD/DALY method, which estimates the disability weights and prevalence of conditions
separately. In the HRQoL used in this study method, changes in prevalence due to
variations in diagnostic threshold should at least partly be compensated by changes in
measured severity, which can be important especially for psychiatric disorders. A
representative, population based sample is necessary in order to estimate the true public
health burden of disorders. Most HRQoL studies are based on clinical or otherwise selected
samples, which make the results difficult to generalize. This study had a large sample
including people living in institutions, oversampling of old people and high response rate
yielding results that are representative of the Finnish population.
A thorough list of somatic conditions was included and, to the author’s knowledge, Health
2000 was the first survey to include reliably diagnosed psychiatric conditions and two
different utility-based HRQoL measures. Psychiatric disorders can not be reliably
diagnosed with questionnaires used in most previous surveys, which has led to either
varying prevalence estimates or exclusion of psychiatric disorders in previous studies.
Reliable diagnostics of psychiatric conditions is necessary in order to inform health
policy and medical decision making: decisions can not be made from how many people report
"anxiety" or "feeling depressed", but should be based on clearly defined syndromes that
can ideally be treated with evidence-based methods. Using reliable diagnosis of alcohol
use disorders was also necessary for identifying those abstainers with previous alcohol
problems.
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However, all chronic conditions could obviously not be included, and including only
conditions that, based on participants’ self-report, had been diagnosed by a physician may
have led to underdiagnosis. Especially worth noticing is that Alzheimer’s disease was not
included, although it has previously been found to greatly impact on HRQoL (Schultz and
Kopec 2003); Alzheimer’s can not be reliably diagnosed or its impact on HRQoL reliably
estimated using self-report. Also many important psychiatric disorders were not included
due to practical reasons. This study protocol was long and rather demanding for the
participants, so people with the most severe disorders were likely to drop out. Although
the sample was relatively large, some conditions were rather rare in some age groups,
leading to decreased statistical power. Considering this, the fact that most chronic
conditions were statistically significantly associated with lowered HRQoL in most age
groups suggests good construct validity of the HRQoL measures. A special case is
psychosis, which can not be reliably diagnosed even with the CIDI interview method
(Regier, Kaelber et al. 1998), so this study included psychoses if they were
self-reported, or the physician conducting the health examination considered the
participant to have a probable psychotic disorder. This method later showed to have good
specificity but poor sensitivity (Perälä, Suvisaari et al. 2007), meaning that the public
health impact of psychosis (Study I) and the group of mental disorders (Study II) are
known to be underestimations. However, not all somatic conditions could be included
either, but the study concentrates on the most common, chronic conditions.
A general limitation of the study is that the survey data were cross-sectional, so no firm
conclusions about causality can be drawn; further longitudinal studies are warranted.
6.3.2 HRQoL measurement
There are two specific issues where the challenges of psychiatric epidemiology and HRQoL
measurement meet: first, mental disorders may distort the way people report their HRQoL,
and second, the descriptive diagnostic categorizations used in psychiatry may lead to
measurement redundancy. Cognitive, affective or psychotic symptoms may distort the way the
person perceives his/her HRQoL. The likelihood of this is may vary from one disorder to
another, and according to disorder severity at the individual level (Katschnig, Freeman et
al. 2006). If the HRQoL instruments and the diagnostic classification have similar domains
this can lead to measurement redundancy. For example, both 15D and EQ-5D have dimensions
with considerable overlap with diagnostic criteria of anxiety and depressive disorders.
So, because feelings of anxiety and depression are a part of HRQoL as defined by these
measures, it is not surprising that anxiety and depressive disorders influence HRQoL.
However, this does not make the impact less real, nor does it discredit the main focus of
this study: comparing the magnitude of the impact of different conditions on utility-based
HRQoL. Furthermore, using the main alternative to HRQoL and QALYs - DALYs, i.e.
disability-adjusted life years with expert-derived preference weights for diagnoses would
also have been very problematic. This is especially true in psychiatry where, as this
study also shows, diagnostic groups appear to hide the fundamental individual-level
variation in the severity of the disorders.
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A strength of the Health 2000 survey is that it included two different HRQoL instruments,
the EQ-5D and the 15D. This permits a more valid estimation of health utility loss
associated with different disorders because, as previous studies and this study also
showed, different HRQoL measures can produce somewhat different results despite being
utility-based. In particular the EQ-5D seems to differ from most other instruments in that
it has a higher ceiling rate, longer scale and less continuous score distributions than
other measures (Tengs and Wallace 2000; Franks, Hanmer et al. 2006). Thus, EQ-5D is
problematic in (at least) general population studies, despite being one of the most
evaluated and used HRQoL measures (Garratt, Schmidt et al. 2002; Räsänen, Roine et al.
2006). The 15D is more sensitive in detecting deviations from full health (Hawthorne,
Richardson et al. 2001; Stavem, Bjornaes et al. 2001). Furthermore, the changes in the
EQ-5D index were almost twice as large as those in the 15D index, again in line with
previous findings (Hawthorne, Richardson et al. 2001). However, this study also found
significant and systematic differences in the rank order of disease severity between the
two measures. The EQ-5D appeared to emphasize the relative impact of musculoskeletal
disorders and migraine, whereas the 15D emphasized the relative impact of lung diseases,
psychiatric disorders, urinary incontinence and heart failure. This is problematic, as
previous studies have suggested that the differences between health utility measures are
primarily differences in magnitude of effects (which can be taken into account
statistically) but not in the rank order of disorders (which is more difficult to control)
(Franks, Hanmer et al. 2006). However, formal comparisons of the two HRQoL measures were
not performed, as they were not included in the same wave of the survey and there was a
delay of approximately one month between the measures.
Important theoretical problems in the use of preference-based HRQoL measures are the
cross-national applicability of the results and use of same preferences for health
utility estimation for all groups of people. If the valuations used to form the HRQoL
scores differ significantly between countries, they accurately reflect only the
preferences of the country where they were elicited. This could theoretically be behind
the differences found between the 15D and the EQ-5D. However, the Finnish VAS-based EQ-
5D valuations have been compared to those in USA (Johnson, Ohinmaa et al. 2000), UK and
other European countries (Sintonen, Weijnen et al. 2003), and only minor differences
between the countries were found. In addition, further analysis of the data of Study I
using the Finnish VAS-based valuation algorithm for the EQ-5D produced no significant
change in the differences between the 15D and the EQ-5D results. The applicability of a
single set of population preferences to all people is, despite being the standard way of
using HRQoL measures, a problematic assumption especially regarding the severity of
conditions at different ages. Furthermore, even if the value people themselves would place
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on health at different ages were constant, from the societal perspective people appear to
value health benefits accruing to young higher than equal benefits for older people (Dolan,
Shaw et al. 2005). This means that, although the health losses would grow with the ageing
population by a quarter up to 2040 as estimated in Study II, it is unclear whether the
patients themselves, or the society, will actually feel that the disease burden we need
to be concerned about actually increases that much.
The statistical analysis of HRQoL measures is complex because they do not generally
satisfy the distributional assumptions required by traditional OLS or Tobit regression
models. The finding of this study that use of different statistical methods had a much
smaller effect on the 15D than on the EQ-5D results was expected (Clarke, Gray et al.
2002), as the 15D has a lower censoring rate and more evenly distributed scores. It is
reassuring that the choice of regression methods between OLS, Tobit or CLAD appears to
have little significance for the 15D. However, this is not the case for the EQ-5D, so the
Tobit estimates presented for the EQ-5D should be interpreted with this limitation in
mind. Still, this study opted for Tobit analyses, as CLAD regression estimates the effects
of explanatory variables on the median of HRQoL, whereas Tobit estimates the effects on
the mean. The use of the median is problematic in the context of QALYs at the group level,
because traditionally the average number of QALYs reflects the gains and losses of each
individual. The differences in results between the 15D and the EQ-5D hardly arise from
statistical factors, as they are observable in the raw scores and also persisted when the
CLAD estimator was used. In sum, our study shows that if the length of the questionnaire
is not a problem, 15D is preferable to EQ-5D in general population surveys.
Although this study aimed at estimating the individual, additive contribution of each
conditions or group of condition to HRQoL, it is likely that in reality the effects are
not always additive, i.e. comorbid forms of conditions might affect HRQoL differently from
pure forms (Baumeister, Balke et al. 2005). This was investigated in Study III by
analysing pure forms of conditions in addition to controlling for other conditions with
regression techniques. The assumption for mostly additive effects between different DSM-IV
disorders was supported by the similarity of these two estimates, but this was not tested
for somatic conditions for practical reasons.
It is important to emphasise that the annual QALY loss estimates consider only morbidity
and do not include mortality. The fraction of total QALYs lost due to morbidity is small
for conditions with high mortality such as cancer and heart diseases. Morbidity accounts
for most of the burden of musculoskeletal disorders, whereas mental, neurological and
pulmonary disorders and accidents appear to fall in between (Manuel, Schultz et al. 2002).
In other words, if mortality was included, this would increase the relative burden of most
disorders except musculoskeletal. The relative importance of mortality also increases with
age. For example, the Swedish burden of disease study (Peterson, Backlund et al. 1998)
estimated that morbidity accounts for 68% of total disease burden at ages 15-44, 39% at
45-64, 30% at 65-84 and 37% at ages over 85 years. The predicted QALY losses in Finland
for the year 2040 have the obvious limitation of assuming that the morbidity situation
remains constant.
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6.4 Implications for further research
This study has described the HRQoL of Finns with different chronic conditions. This is
useful for health policy in many ways, but there are also important limitations suggesting
further research. First, cross-sectional studies can not ascertain causality, so
longitudinal research is warranted in order to more accurately decipher the impacts of
diseases and disorders. Second, from a health policy perspective, the marginal effects of
interventions and treatments in the real health care setting would be the ideal
information needed for rational public health policy. In other words: the current study
shows where the largest HRQoL losses - and largest theoretical gains - are. However, it
does not show how, if at all, these gains can be realized. The results are important in
guiding future research and development: an ideal way forward would be a follow-up study
to the Health 2000 survey, including further HRQoL measurement, mortality and data on
treatments received. The results are also directly important for health and social policy.
There are plenty of studies showing what could be done to benefit people identified as
having low HRQoL. For example, many people with depressive or anxiety disorders do not
receive adequate treatment, or receive it too late (Alonso, Angermeyer et al. 2004;
Melartin, Rytsälä et al. 2005; Wang, Berglund et al. 2005). Further, it may also be
considered justified purely on ethical grounds to concentrate efforts of help on those who
are worst off (Rawls 1972).
The present series of studies has shown a clear need for further studies estimating the
impact different conditions have on HRQoL, including reliably diagnosed psychiatric
disorders, using general population samples. The added complexity and costs following
inclusion of reliable psychiatric interviews in surveys should not be used to justify
excluding psychiatric conditions, as they are proved to cause a significant proportion of
public health loss, especially at younger ages.
However, measuring only HRQoL of patients has obvious limitations, if the aim is to
improve the global QoL of the whole population. First, a comprehensive QoL assessment
needs to also address subjective life satisfaction and objective life circumstances.
Second, it would be important to consider also the indirect effects of disorders on other
peoples QoL, for example relatives and caregivers. Both of these issues are especially
important for psychiatric disorders.
For psychiatric disorders, especially lacking are studies conducted on population-level
anxiety disorders. This study suggests that the total loss of QALY caused by anxiety
disorders is large and approaches that of depressive disorders. This finding requires
replication, as the clinical and health policy implications can be significant.
Equally in need of replication is the finding that moderate alcohol consumption is
associated with insignificantly improved HRQoL. The notion that moderate alcohol
consumption is beneficial has penetrated the public widely, and alcohol consumption is
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common, so the potential health policy implications of this finding may be large. It is
possible that mortality studies capture most of the beneficial effects of alcohol. Due to
complex causal pathways linking alcohol consumption, abstinence and HRQoL, other study
designs than cross-sectional surveys are needed. Future studies should very carefully
avoid the classification of former drinkers as abstainers.
As our studies have shown, HRQoL measurement also still needs theoretical improvements. If
QALYs have validity, it is unacceptable that two measures claiming to measure the same
thing yield such different results as shown in this study. However, in light of previous
studies, this may be more a problem of the EQ-5D than the whole HRQoL field.
6.5 QALYs, rationing and health policy
In addition to the methodological problems of utility-based HRQoL measures, it is also
still open how QALYs would be best used for resource allocation. Despite the temptation to
opt for pure utilitarian maximising of QALYs, this can not be considered an adequate
method for priority setting as such for several reasons (Holm, Sabin et al. 1998; Dolan,
Shaw et al. 2005). First, HRQoL forms only a part of the whole of quality of life of
individuals, and health care systems have many other legitimate purposes than maximising
HRQoL, such as care, social cohesion, equality, safety and patient satisfaction that can
not be captured by QALYs. In other words, directly applying of QALYs to rationing reduces
the value of human life to HRQoL; hardly a humanistic approach (Arnesen and Nord 1999).
Second, even if public health is obviously always related to real individuals’ health, the
same sum of public health (like the mean change in the HRQoL of the population
concentrated in this study) can be produced by many different individual distributions of
health. To exemplify some problems: a) the same aggregate HRQoL gain can be produced by
increasing one patients HRQoL by 0.3 or thirty patients’ by 0.01. b) is it of an equal
societal or ethical value to increase someone’s HRQoL from 0.2 to 0.4 or from 0.8 to 1.0?
or c) what if the HRQoL of 100 people can be increased from 0.9 to 1.00, if someone’s
HRQoL is reduced from 0.3 to 0? Another important issue relates to age: are QALY gains
equally valuable, if they fall on the young or the old? Even if we ignore the first
concern and aim at maximising public health - however defined - we still need
considerations of justice. Also empirical research suggests that people are generally
willing to sacrifice quality of life maximisation in order to provide benefit to those
with the worst health prospects, and prioritize young people over old people in accordance
with the "fair innings" theory (Dolan, Shaw et al. 2005) . Third, from both ethical and
economical points of view, it is important to know what the incremental and opportunity
costs are, and who will bear them. Fourth, the lack of gold standard in HRQoL research and
the differences in results provided by different measures (as shown in Study I) must be
taken into account.
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In sum, although exact-looking results that claim to show the impact of different
conditions and treatments with three decimal places might be politically convenient, they
may paradoxically in effect obstruct democratic health policy. A convincing argument can
be made that the problems of rationing cannot be solved by rational, simple rules, but
instead require a fair and politically transparent process of decisionmaking (Holm, Sabin
et al. 1998; Culyer 2001; Daniels 2001; Ham and Coulter 2001).
The implication is that if rationing decisions are inherently political, the legitimacy of
the decisions depends on the legitimacy of decision makers. Researchers are rarely
legitimate policymakers, so if quality of life research wishes to legitimately influence
health policy it is important to be transparent about the assumptions and limitations of
the research - despite the temptation and opportunities for disguising value-decisions as
scientific "evidence-based health policy" (Black 2001; Saarni and Gylling 2004). QALYs
emphasise the preferences of people affected with different conditions. If democratic
health policy should be based on preferences of health politicians - and not preferences
the population or the patients - technocratic models based on QALY calculations may hinder
this (Fayers and Machin 2007).
Practically and politically applicable, universally acceptable methods for setting health
priorities are still much needed. Meanwhile, procedural model for rationing developed by
Daniels and Sabin (Daniels and Sabin 1997; Daniels 2001), "accountability for
reasonableness", based on Rawls (Rawls 1972) is a promising starting point. QALYs, as an
expression of patient preferences, can have a legitimate place in priority setting.
Considering the state of the art of QALY measurement, and the ethical issues discussed,
presenting HRQoL profiles and mortality data separately in addition to combining them into
QALYs is probably warranted in most cases.
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7. Conclusions
This study aimed to fill the lack of general population studies with reliable psychiatric
diagnostics and preference-based HRQoL measurement. This study has made clear that
musculoskeletal and psychiatric disorders have a major impact on HRQoL of Finns. For
psychiatric disorders, this is caused by the many dimensions of HRQoL these disorders
influence, the relative importance of mental health dimensions to total HRQoL and the
young age at which these disorders present. Although there is a lack of comparable,
international studies, those that exist confirm these findings especially relating to
psychiatric disorders. Anxiety disorders may need special attention, as their burden seems
larger than previously thought. Considering moderate alcohol use, this study supports the
current policy of not actively recommending anyone to start drinking, as the benefits
commonly attributed to moderate alcohol consumption may be minor and mostly attributable
to misclassification of former drinkers.
Quality of life research is important in bringing to the fore the true burden of different
disorders in a way that respects the individual values of people. This paves the way for
rational public health policymaking that focuses on targets where the biggest problems -
and biggest potential gains - lie. Gains not just in health, but in better quality of life
for all people. This is what health care and health research is for.
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9. Appendices
1. Major preference-based HRQoL instruments
Major HRQoL instruments based on multi-attribute utility theory
Instrument                                 Dimensions         Scale   
15D (Sintonen 1994; Sintonen 1995)             15              0.11 to 1.00
Assesment of Quality of Life (AQoL) 
(Hawthorne, Richardson et al. 1999;
Hawthorne, Richardson et al. 2000)              4             -0.04 to 1.00
EuroQol EQ-5D (1990)                            5             -0.59 to 1.00
Health Utilities Index, mark II (HUI II) 
(Feeny, Furlong et al. 1995; Torrance,
Feeny et al. 1996)                              7             -0.03 to 1.00
Health Utilites Index, mark III (HUI III)
(Feeny, Furlong et al. 1995; Feeny,
Furlong et al. 2002)                            8             -0.36 to 1.00
Rosser-Kind Index (Rosser and Kind 1978)        2             -1.49 to 1.00
Quality of Well-being Index (QWB)
(Kaplan and Anderson 1988)                      4              0.00 to 1.00
Medical Outcomes Study Short Form - 6D (SF-6D)
(Brazier, Usherwood et al. 1998)                6              0.46 to 1.00
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2. The 15D questionnaire.
Copyright Harri Sintonen, reproduced with permission. Downloaded from
www.15d-instrument.net.
Please read through all the alternative responses to each question before placing a cross
(x) against the alternative which best describes your present health status. Continue
through all 15 questions in this manner, giving only one answer to each.
QUESTION 1. MOBILITY
1 ( ) I am able to walk normally (without difficulty) indoors, outdoors and on stairs.
2 ( ) I am able to walk without difficulty indoors, but outdoors and/or on stairs I have
      slight difficulties.
3 ( ) I am able to walk without help indoors (with or without an appliance), but outdoors
      and/or on stairs only with considerable difficulty or with help from others.
4 ( ) I am able to walk indoors only with help from others.
5 ( ) I am completely bed-ridden and unable to move about.
QUESTION 2. VISION 
1 ( ) I see normally, i.e. I can read newspapers and TV text without difficulty (with or
      without glasses).
2 ( ) I can read papers and/or TV text with slight difficulty (with or without glasses).
3 ( ) I can read papers and/or TV text with considerable difficulty (with or without glasses).
4 ( ) I cannot read papers or TV text either with glasses or without, but I can see enough
      to walk about without guidance.
5 ( ) I cannot see enough to walk about without a guide, i.e. I am almost or completely blind.
QUESTION 3. HEARING 
1 ( ) I can hear normally, i.e. normal speech (with or without a hearing aid).
2 ( ) I hear normal speech with a little difficulty.
3 ( ) I hear normal speech with considerable difficulty; in conversation I need voices to
      be louder than normal.
4 ( ) I hear even loud voices poorly; I am almost deaf.
5 ( ) I am completely deaf.
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QUESTION 4. BREATHING 
1 ( ) I am able to breathe normally, i.e. with no shortness of breath or other breathing
      difficulty.
2 ( ) I have shortness of breath during heavy work or sports, or when walking briskly on
      flat ground or slightly uphill.
3 ( ) I have shortness of breath when walking on flat ground at the same speed as others
      my age.
4 ( ) I get shortness of breath even after light activity, e.g. washing or dressing myself.
5 ( ) I have breathing difficulties almost all the time, even when resting.
QUESTION 5. SLEEPING
1 ( ) I am able to sleep normally, i.e. I have no problems with sleeping.
2 ( ) I have slight problems with sleeping, e.g. difficulty in falling asleep, or
      sometimes waking at night.
3 ( ) I have moderate problems with sleeping, e.g. disturbed sleep, or feeling I have not
      slept enough.
4 ( ) I have great problems with sleeping, e.g. having to use sleeping pills often or
      routinely, or usually waking at night and/or too early in the morning.
5 ( ) I suffer severe sleeplessness, e.g. sleep is almost impossible even with full use of
      sleeping pills, or staying awake most of the night.
QUESTION 6. EATING
1 ( ) I am able to eat normally, i.e. with no help from others.
2 ( ) I am able to eat by myself with minor difficulty (e.g. slowly, clumsily, shakily, or
      with special appliances).
3 ( ) I need some help from another person in eating.
4 ( ) I am unable to eat by myself at all, so I must be fed by another person.
5 ( ) I am unable to eat at all, so I am fed either by tube or intravenously.
QUESTION 7. SPEECH
1 ( ) I am able to speak normally, i.e. clearly, audibly and fluently.
2 ( ) I have slight speech difficulties, e.g. occasional fumbling for words, mumbling, or
      changes of pitch.
3 ( ) I can make myself understood, but my speech is e.g. disjointed, faltering,
      stuttering or stammering.
4 ( ) Most people have great difficulty understanding my speech.
5 ( ) I can only make myself understood by gestures.
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QUESTION 8. ELIMINATION
1 ( ) My bladder and bowel work normally and without problems.
2 ( ) I have slight problems with my bladder and/or bowel function, e.g. difficulties with
      urination, or loose or hard bowels.
3 ( ) I have marked problems with my bladder and/or bowel function, e.g. occasional
      ’accidents’, or severe constipation or diarrhea.
4 ( ) I have serious problems with my bladder and/or bowel function, e.g. routine
      ’accidents’, or need of catheterization or enemas.
5 ( ) I have no control over my bladder and/or bowel function.
QUESTION 9. USUAL ACTIVITIES
1 ( ) I am able to perform my usual activities (e.g. employment, studying, housework,
      free-time activities) without difficulty.
2 ( ) I am able to perform my usual activities slightly less effectively or with minor
      difficulty.
3 ( ) I am able to perform my usual activities much less effectively, with considerable
      difficulty, or not completely.
4 ( ) I can only manage a small proportion of my previously usual activities.
5 ( ) I am unable to manage any of my previously usual activities.
QUESTION 10. MENTAL FUNCTION
1 ( ) I am able to think clearly and logically, and my memory functions well
2 ( ) I have slight difficulties in thinking clearly and logically, or my memory sometimes
      fails me.
3 ( ) I have marked difficulties in thinking clearly and logically, or my memory is
      somewhat impaired.
4 ( ) I have great difficulties in thinking clearly and logically, or my memory is
      seriously impaired.
5 ( ) I am permanently confused and disoriented in place and time.
QUESTION 11. DISCOMFORT AND SYMPTOMS
1 ( ) I have no physical discomfort or symptoms, e.g. pain, ache, nausea, itching etc.
2 ( ) I have mild physical discomfort or symptoms, e.g. pain, ache, nausea, itching etc.
3 ( ) I have marked physical discomfort or symptoms, e.g. pain, ache, nausea, itching etc.
4 ( ) I have severe physical discomfort or symptoms, e.g. pain, ache, nausea, itching etc.
5 ( ) I have unbearable physical discomfort or symptoms, e.g. pain, ache, nausea, itching etc.
QUESTION 12. DEPRESSION
1 ( ) I do not feel at all sad, melancholic or depressed.
2 ( ) I feel slightly sad, melancholic or depressed.
3 ( ) I feel moderately sad, melancholic or depressed.
4 ( ) I feel very sad, melancholic or depressed.
5 ( ) I feel extremely sad, melancholic or depressed.
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QUESTION 13. DISTRESS
1 ( ) I do not feel at all anxious, stressed or nervous.
2 ( ) I feel slightly anxious, stressed or nervous.
3 ( ) I feel moderately anxious, stressed or nervous.
4 ( ) I feel very anxious, stressed or nervous.
5 ( ) I feel extremely anxious, stressed or nervous.
QUESTION 14. VITALITY
1 ( ) I feel healthy and energetic.
2 ( ) I feel slightly weary, tired or feeble.
3 ( ) I feel moderately weary, tired or feeble.
4 ( ) I feel very weary, tired or feeble, almost exhausted.
5 ( ) I feel extremely weary, tired or feeble, totally exhausted.
QUESTION 15. SEXUAL ACTIVITY
1 ( ) My state of health has no adverse effect on my sexual activity.
2 ( ) My state of health has a slight effect on my sexual activity.
3 ( ) My state of health has a considerable effect on my sexual activity.
4 ( ) My state of health makes sexual activity almost impossible.
5 ( ) My state of health makes sexual activity impossible.
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3. The EQ-5D questionnaire
Copyright the EuroQoL group. Reproduced with permission.
By placing a checkmark in one box in each group below, please indicate which statements
best describe your own health state today.
QUESTION 1. MOBILITY 
1 ( ) I have no problems in walking about
2 ( ) I have some problems in walking about
3 ( ) I am confined to bed
QUESTION 2. SELF-CARE
1 ( ) I have no problems with self-care
2 ( ) I have some problems washing or dressing myself
3 ( ) I am unable to wash or dress myself
QUESTION 3. USUAL ACTIVITIES (e.g., work, study, housework, family, or leisure activities)
1 ( ) I have no problems with performing my usual activities
2 ( ) I have some problems with performing my usual activities
3 ( ) I am unable to perform my usual activities
QUESTION 4. PAIN / DISCOMFORT 
1 ( ) I have no pain or discomfort
2 ( ) I have moderate pain or discomfort
3 ( ) I have extreme pain or discomfort
QUESTION 5. ANXIETY / DEPRESSION
1 ( ) I am not anxious or depressed
2 ( ) I am moderately anxious or depressed
3 ( ) I am extremely anxious or depressed
74
10. REFERENCES
(1990). "EuroQol-a new facility for the measurement of health-related quality of life. The
EuroQoL Group." Health Policy 16(3): 199-208.
(1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington,
American Psychiatric Association.
Alonso, J., M. C. Angermeyer, et al. (2004). "Disability and quality of life impact of
mental disorders in Europe: results from the European Study of the Epidemiology of Mental
Disorders (ESEMeD) project." Acta Psychiatr Scand Suppl(420): 38-46.
Alonso, J., M. C. Angermeyer, et al. (2004). "Use of mental health services in Europe:
results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project."
Acta Psychiatr Scand Suppl(420): 47-54.
Alonso, J., M. Ferrer, et al. (2004). "Health-related quality of life associated with
chronic conditions in eight countries: results from the International Quality of Life
Assessment (IQOLA) Project." Qual Life Res 13(2): 283-98.
Arnesen, T. and E. Nord (1999). "The value of DALY life: problems with ethics and validity
of disability adjusted life years." Bmj 319(7222): 1423-5.
Aromaa, A. and S. Koskinen, Eds. (2004). Health and Functional Capacity in Finland.
Baseline Results of the Health 2000 Health Examination Survey. Helsinki, Publications of
the National Public Health Institute. http://www.ktl.fi/health2000/julkaisut/baseline.pdf.
Austin, P. C. (2002). "A comparison of methods for analyzing health-related
quality-of-life measures." Value Health 5(4): 329-37.
Austin, P. C., M. Escobar, et al. (2000). "The use of the Tobit model for analyzing
measures of health status." Qual Life Res 9(8): 901-10.
Barton, G. R., T. H. Sach, et al. (2007). "An assessment of the discriminative ability of
the EQ- 5D(index), SF-6D, and EQ VAS, using sociodemographic factors and clinical
conditions." Eur J Health Econ.
Baumeister, H., K. Balke, et al. (2005). "Psychiatric and somatic comorbidities are
negatively associated with quality of life in physically ill patients." J Clin Epidemiol
58(11): 1090-100.
75
Bijl, R. and A. Ravelli (2000). "Current and residual functional disability associated
with psychopathology: findings from the Netherlands Mental Health Survey and Incidence
Study (NEMESIS)." Psychological Medicine 30: 657-668.
Black, N. (2001). "Evidence Based Policy - Proceed with care." British Medical Journal
323: 275-279.
Bowling, A. (1996). "The effects of illness on quality of life: findings from a survey of
households in Great Britain." J Epidemiol Community Health 50(2): 149-55.
Brazier, J., T. Usherwood, et al. (1998). "Deriving a preference-based single index from
the UK SF-36 Health Survey." J Clin Epidemiol 51(11): 1115-28.
Brock, D. (1993). Quality of Life Measures in Health Care and Medical Ethics. The Quality
of Life. M. Nussbaum and A. Sen. Oxford, Clarendon Press.
Brooks, R. (1996). "EuroQol: the current state of play." Health Policy 37(1): 53-72.
Burström, K., M. Johannesson, et al. (2001). "Health-related quality of life by disease
and socio-economic group in the general population in Sweden." Health Policy 55(1):
51-69.
Burström, K., M. Johannesson, et al. (2001). "Swedish population health-related quality of
life results using the EQ-5D." Qual Life Res 10(7): 621-35.
Chisholm, D., A. Healey, et al. (1997). "QALYs and mental health care." Soc Psychiatry
Psychiatr Epidemiol 32(2): 68-75.
Clarke, P., A. Gray, et al. (2002). "Estimating utility values for health states of type 2
diabetic patients using the EQ-5D (UKPDS 62)." Med Decis Making 22(4): 340-9.
Cong, R. (2000). "Marginal effects for the tobit model." Stata Technical Bulletin(July,
STB-56): 27-34.
Culyer, A. J. (2001). "Economics and ethics in health care." J Med Ethics 27(4): 217-22.
Daniels, N. (2001). "Justice, health, and healthcare." Am J Bioeth 1(2): 2-16.
Daniels, N. and J. Sabin (1997). "Limits to health care: fair procedures, democratic
deliberation, and the legitimacy problem for insurers." Philos Public Aff 26(4): 303-50.
76
Di Castelnuovo, A., S. Costanzo, et al. (2006). "Alcohol dosing and total mortality in men
and women: an updated meta-analysis of 34 prospective studies." Arch Intern Med 166(22):
2437-45.
Dolan, P. (1997). "Modeling valuations for EuroQol health states." Med Care 35(11):
1095-108.
Dolan, P. (2000). The measurement of health-related quality of life for use in resource
allocation desicions in health care. Handbook of Health Economics. A. J. Culyer and J. P.
Newhouse. Amsterdam, Elsevier: 1723-1760.
Dolan, P., C. Gudex, et al. (1996). "The time trade-off method: results from a general
population study." Health Econ 5(2): 141-54.
Dolan, P., R. Shaw, et al. (2005). "QALY maximisation and people’s preferences: a
methodological review of the literature." Health Econ 14(2): 197-208.
Donovan, D., M. E. Mattson, et al. (2005). "Quality of life as an outcome measure in
alcoholism treatment research." J Stud Alcohol Suppl(15): 119-39; discussion 92-3.
Eigenbrodt, M. L., F. D. Fuchs, et al. (2006). "Changing drinking pattern does not
influence health perception: a longitudinal study of the atherosclerosis risk in
communities study." J Epidemiol Community Health 60(4): 345-50.
El-Guebaly, N. (2007). "Investigating the association between moderate drinking and mental
health." Ann Epidemiol 17(5 Suppl): S55-62.
Fayers, P. and D. Machin (2007). Quality of Life. The assessment, analysis and
interpretation of patient-reported outcomes. Second edition. . Chichester, John Wiley &
Sons.
Feeny, D., W. Furlong, et al. (1995). "Multi-attribute health status classification
systems. Health Utilities Index." Pharmacoeconomics 7(6): 490-502.
Feeny, D., W. Furlong, et al. (2002). "Multiattribute and single-attribute utility
functions for the health utilities index mark 3 system." Med Care 40(2): 113-28.
Fillmore, K. M., J. M. Golding, et al. (1998). "Alcohol consumption and mortality. I.
Characteristics of drinking groups." Addiction 93(2): 183-203.
Fillmore, K. M., W. Kerr, et al. (2006). "Moderate alcohol use and reduced mortality risk.
Systematic error in prospective studies." Addict Res Theory 14: 101-132.
77
Fillmore, K. M., T. Stockwell, et al. (2007). "Moderate alcohol use and reduced mortality
risk: systematic error in prospective studies and new hypotheses." Ann Epidemiol 17(5
Suppl): S16-23.
Foster, J. H., T. J. Peters, et al. (2002). "Quality of life, sleep, mood and alcohol
consumption: a complex interaction." Addict Biol 7(1): 55-65.
Foster, J. H., J. E. Powell, et al. (1999). "Quality of life in alcohol-dependent
subjects-a review." Qual Life Res 8(3): 255-61.
Franks, P., J. Hanmer, et al. (2006). "Relative disutilities of 47 risk factors and
conditions assessed with seven preference-based health status measures in a national U.S.
sample: toward consistency in cost-effectiveness analyses." Med Care 44(5): 478-85.
French, M. T. and S. K. Zavala (2007). "The health benefits of moderate drinking
revisited: alcohol use and self-reported health status." Am J Health Promot 21(6): 484-91.
Fryback, D. G., E. J. Dasbach, et al. (1993). "The Beaver Dam Health Outcomes Study:
initial catalog of health-state quality factors." Med Decis Making 13(2): 89-102.
Garratt, A., L. Schmidt, et al. (2002). "Quality of life measurement: bibliographic study
of patient assessed health outcome measures." Bmj 324(7351): 1417.
Gmel, G., E. Gutjahr, et al. (2003). "How stable is the risk curve between alcohol and
all-cause mortality and what factors influence the shape? A precision-weighted
hierarchical meta-analysis." Eur J Epidemiol 18(7): 631-42.
Gold, M. R., D. Stevenson, et al. (2002). "HALYS and QALYS and DALYS, Oh My: similarities
and differences in summary measures of population Health." Annu Rev Public Health 23:
115-34.
Goldberg, D. P. (1972). The detection of psychiatric illness by questionnaire. London,
Oxford University Press.
Goldberg, D. P., R. Gater, et al. (1997). "The validity of two versions of the GHQ in the
WHO study of mental illness in general health care." Psychol Med 27(1): 191-7.
Guallar-Castillon, P., F. Rodriguez-Artalejo, et al. (2001). "Consumption of alcoholic
beverages and subjective health in Spain." J Epidemiol Community Health 55(9): 648-52.
Ham, C. and A. Coulter (2001). "Explicit and implicit rationing: taking responsibility and
avoiding blame for health care choices." J Health Serv Res Policy 6(3): 163-9.
78
Hawthorne, G., J. Richardson, et al. (2001). "A comparison of the Assessment of Quality of
Life (AQoL) with four other generic utility instruments." Ann Med 33(5): 358-70.
Hawthorne, G., J. Richardson, et al. (2000). Construction and Utility Scaling of the
Assessment of Quality of Life (AQoL) Instrument. Melbourne, Centre for Health Program
Evaluation.
Hawthorne, G., J. Richardson, et al. (1999). "The Assessment of Quality of Life (AQoL)
instrument: a psychometric measure of health-related quality of life." Qual Life Res 8(3):
209-24.
Heistaro, S., Ed. (2005). Menetelmäraportti. Terveys 2000 - tutkimuksen toteutus, aineisto
ja menetelmät (Implementation, Data, and Methods of the Health 2000 Survey [in Finnish]).
Publications of the National Public Health Institute. Helsinki, National Public Health
Institute.
Hingson, R., N. Scotch, et al. (1981). "Life satisfaction and drinking practices in the
Boston metropolitan area." J Stud Alcohol 42(1): 24-37.
Holi, M. M., M. Marttunen, et al. (2003). "Comparison of the GHQ-36, the GHQ-12 and the
SCL-90 as psychiatric screening instruments in the Finnish population." Nord J Psychiatry
57(3): 233-8.
Holm, S., J. Sabin, et al. (1998). "The second phase of priority setting." Bmj 317(7164):
1000-7.
Häkkinen, U., M. R. Järvelin, et al. (2006). "Health, schooling and lifestyle among young
adults in Finland." Health Econ 15(11): 1201-16.
Isacson, D., K. Bingefors, et al. (2005). "The impact of depression is unevenly
distributed in the population." Eur Psychiatry 20(3): 205-12.
Johansson, E., H. Alho, et al. (2006). "Abstaining from alcohol and labour market
underperformance-have we forgotten the ’dry’ alcoholics?" Alcohol Alcohol 41(5): 574-9.
Johnson, J. A. and S. J. Coons (1998). "Comparison of the EQ-5D and SF-12 in an adult US
sample." Qual Life Res 7(2): 155-66.
Johnson, J. A., A. Ohinmaa, et al. (2000). "Comparison of Finnish and U.S.-based visual
analog scale valuations of the EQ-5D measure." Med Decis Making 20(3): 281-9.
Johnson, J. A. and A. S. Pickard (2000). "Comparison of the EQ-5D and SF-12 health surveys
in a general population survey in Alberta, Canada." Med Care 38(1): 115-21.
79
Kaplan, R. M. and J. P. Anderson (1988). "A general health policy model: update and
applications." Health Serv Res 23(2): 203-35.
Katschnig, H., H. Freeman, et al., Eds. (2006). Quality of Life in Mental Disorders.
Chichester, John Wiley & Sons
Kind, P., G. Hardman, et al. (1999). UK Population Norms for EQ-5D. Discussion Paper 172.
University of York, The Centre for Health Economics.
Klein, D. N., S. A. Shankman, et al. (2007). "Dysthymic disorder and double depression:
Prediction of 10-year course trajectories and outcomes." J Psychiatr Res.
Koivumaa-Honkanen, H., R. Honkanen, et al. (2000). "Self-reported life satisfaction and
20-year mortality in healthy Finnish adults." Am J Epidemiol 152(10): 983-91.
Kopec, J. A. and K. D. Willison (2003). "A comparative review of four preference-weighted
measures of health-related quality of life." J Clin Epidemiol 56(4): 317-25.
Lubetkin, E. I., H. Jia, et al. (2005). "Relationship Among Sociodemographic Factors,
Clinical Conditions, and Health-related Quality of Life: Examining the EQ-5D in the U.S.
General Population." Qual Life Res 14(10): 2187-96.
Manuel, D. G., S. E. Schultz, et al. (2002). "Measuring the health burden of chronic
disease and injury using health adjusted life expectancy and the Health Utilities Index."
J Epidemiol Community Health 56(11): 843-50.
Mathers, C. D., E. T. Vos, et al. (1999). The burden of disease and injury in australia.
Canberra, AIHW.
McDonald, J. F. and R. A. Moffitt (1980). "The uses of Tobit analysis." The Review of
Economic and Statistics 62: 318-321.
Melartin, T. K., H. J. Rytsälä, et al. (2005). "Continuity is the main challenge in
treating major depressive disorder in psychiatric care." J Clin Psychiatry 66(2): 220-7.
Melse, J. M., M. L. Essink-Bot, et al. (2000). "A national burden of disease calculation:
Dutch disability-adjusted life-years. Dutch Burden of Disease Group." Am J Public Health
90(8): 1241-7.
Michelson, H., C. Bolund, et al. (2000). "Multiple chronic health problems are negatively
associated with health related quality of life (HRQoL) irrespective of age." Qual Life Res
9(10): 1093-104.
80
Mittmann, N., K. Trakas, et al. (1999). "Utility scores for chronic conditions in a
community-dwelling population." Pharmacoeconomics 15(4): 369-76.
Mooney, G. and V. Wiseman (2000). "Burden of disease and priority setting." Health Econ
9(5): 369-72.
Murray, C. J. and A. D. Lopez, Eds. (1996). The Global Burden of Disease: A Comprehensive
Assessment of Mortality and Disability From Diseases, Injuries and Risk Factors in 1990
and Projected to 2020. Boston, Mass., Harvard University Press.
Murray, C. J. and A. D. Lopez (2000). "Progress and directions in refining the global
burden of disease approach: a response to Williams." Health Econ 9(1): 69-82.
Murray, C. J., J. A. Salomon, et al. (2000). "A critical examination of summary measures
of population health." Bull World Health Organ 78(8): 981-94.
Nussbaum, M. and A. Sen, Eds. (1993). The Quality of Life. Oxford, Oxford University
Press.
OECD (1982). The OECD list of social indicators. Paris, Organisation for Economic
Co-operation and Development.
Ormel, J., M. VonKorff, et al. (1994). "Common mental disorders and disability across
cultures. Results from the WHO Collaborative Study on Psychological Problems in General
Health Care." Jama 272(22): 1741-8.
Perälä, J., J. Suvisaari, et al. (2007). "Lifetime prevalence of psychotic and bipolar I
disorders in a general population." Arch Gen Psychiatry 64(1): 19-28.
Peterson, S., I. Backlund, et al. (1998). Sjukdomsbördan i Sverige - en svensk
DALY-kalkyl. Stockholm, Folkhälsoinstitutet.
Pirkola, S. P., E. Isometsä, et al. (2005). "DSM-IV mood-, anxiety- and alcohol use
disorders and their comorbidity in the Finnish general population Results from the Health
2000 Study." Soc Psychiatry Psychiatr Epidemiol 40(1): 1-10.
Poikolainen, K., E. Vartiainen, et al. (1996). "Alcohol intake and subjective health." Am
J Epidemiol 144(4): 346-50.
Powell, J. (1984). "Least absolute deviations estimation for the censored regression
model." Journal of Econometrics 25: 303-325.
81
Power, C., B. Rodgers, et al. (1998). "U-shaped relation for alcohol consumption and
health in early adulthood and implications for mortality." Lancet 352(9131): 877.
Rabin, R. and F. de Charro (2001). "EQ-5D: a measure of health status from the EuroQol
Group." Ann Med 33(5): 337-340.
Rawls, J. (1972). A Theory of Justice. New York, Oxford University Press.
Regier, D. A., C. T. Kaelber, et al. (1998). "Limitations of diagnostic criteria and
assessment instruments for mental disorders. Implications for research and policy."
Archives of General Psychiatry 55(2): 109-115.
Rimm, E. B. and C. Moats (2007). "Alcohol and coronary heart disease: drinking patterns
and mediators of effect." Ann Epidemiol 17(5 Suppl): S3-7.
Roberts, R., E. Brunner, et al. (1995). "Psychological factors in the relationship between
alcohol and cardiovascular morbidity." Soc Sci Med 41(11): 1513-6.
Rosser, R. and P. Kind (1978). "A scale of valuations of states of illness: is there a
social consensus?" Int J Epidemiol 7(4): 347-58.
Räsänen, P., E. Roine, et al. (2006). "Use of quality-adjusted life years for the
estimation of effectiveness of health care: A systematic literature review." Int J Technol
Assess Health Care 22(2): 235-41.
Saarni, S. I. and H. A. Gylling (2004). "Evidence based medicine guidelines: a solution to
rationing or politics disguised as science?" J Med Ethics 30(2): 171-5.
Saito, I., T. Okamura, et al. (2005). "A cross-sectional study of alcohol drinking and
health-related quality of life among male workers in Japan." J Occup Health 47(6):
496-503.
Sales, E. (2003). "Family burden and quality of life." Qual Life Res 12 Suppl 1: 33-41.
San Jose, B., H. van de Mheen, et al. (1999). "The U-shaped curve: various health measures
and alcohol drinking patterns." J Stud Alcohol 60(6): 725-31.
Sareen, J., M. B. Stein, et al. (2005). "The relation between perceived need for mental
health treatment, DSM diagnosis, and quality of life: a Canadian population-based survey."
Can J Psychiatry 50(2): 87-94.
82
Schmitz, N., J. Kruse, et al. (1999). "Psychometric properties of the General Health
Questionnaire (GHQ-12) in a German primary care sample." Acta Psychiatr Scand 100(6):
462-8.
Schultz, S. E. and J. A. Kopec (2003). "Impact of chronic conditions." Health Rep 14(4):
41-53.
Singer, M. A., W. M. Hopman, et al. (1999). "Physical functioning and mental health in
patients with chronic medical conditions." Qual Life Res 8(8): 687-91.
Sintonen, H. (1994). The 15D Measure of Health Related Quality of Life: Reliability,
Validity and Sensitivity of its Health State Descriptive System. Melbourne, Centre for
Health Program Evaluation, Monash University.
Sintonen, H. (1994). "Outcome Measurement in Acid-Related Diseases." Pharmacoeconomics
5(S3): 17-26.
Sintonen, H. (1995). The 15D Measure of Health Related Quality of Life. II Feasibility,
Reliability and Validity of its Valuation System. Melbourne, Centre for Health Program
Evaluation, Monash University.
Sintonen, H. (2001). "The 15D instrument of health-related quality of life: properties and
applications." Ann Med 33(may): 328-336.
Sintonen, H., T. Weijnen, et al. (2003). Comparison of EQ-5D valuations: analysis of
background variables. The Measurement and Valuation of Health Status using EQ-5D: A
European Perspective. Evidence from the EuroQoL BIOMED research programme. R. Brooks, R.
Rabin and F. de Charro. Dordrecht, Kluwer Academic Publishers: 81-101.
Sprangers, M. A., E. B. de Regt, et al. (2000). "Which chronic conditions are associated
with better or poorer quality of life?" J Clin Epidemiol 53(9): 895-907.
StataCorp (2003). STATA Users Guide Release 8. College Station, Texas, Stata Press.
Stavem, K., H. Bjornaes, et al. (2001). "Properties of the 15D and EQ-5D utility measures
in a community sample of people with epilepsy." Epilepsy Res 44(2-3): 179-89.
Stranges, S., J. Notaro, et al. (2006). "Alcohol drinking pattern and subjective health in
a population-based study." Addiction 101(9): 1265-76.
Sullivan, P. W., W. F. Lawrence, et al. (2005). "A national catalog of preference-based
scores for chronic conditions in the United States." Med Care 43(7): 736-49.
83
Tengs, T. O. and A. Wallace (2000). "One thousand health-related quality-of-life
estimates." Med Care 38(6): 583-637.
Tobin, J. (1958). "Estimation of Relationships for Limited Dependent Variables."
Econometrica 26: 24-36.
Torrance, G. W., D. H. Feeny, et al. (1996). "Multiattribute utility function for a
comprehensive health status classification system. Health Utilities Index Mark 2." Med
Care 34(7): 702-22.
Walters, S. J. and J. E. Brazier (2005). "Comparison of the minimally important difference
for two health state utility measures: EQ-5D and SF-6D." Qual Life Res 14(6): 1523-32.
van Dijk, A. P., J. Toet, et al. (2004). "The relationship between health-related quality
of life and two measures of alcohol consumption." J Stud Alcohol 65(2): 241-9.
Wang, J. J., W. Smith, et al. (2006). "Variables determining perceived global health
ranks: findings from a population-based study." Ann Acad Med Singapore 35(3): 190-7.
Wang, P. S., P. Berglund, et al. (2005). "Failure and delay in initial treatment contact
after first onset of mental disorders in the National Comorbidity Survey Replication."
Arch Gen Psychiatry 62(6): 603-13.
Ware, J. E., Jr. and C. D. Sherbourne (1992). "The MOS 36-item short-form health survey
(SF-36). I. Conceptual framework and item selection." Med Care 30(6): 473-83.
Wells, K. B. and C. D. Sherbourne (1999). "Functioning and utility for current health of
patients with depression or chronic medical conditions in managed, primary care
practices." Arch Gen Psychiatry 56(10): 897-904.
WHO (1946). Preamble to the Constitution of the World Health Organization as adopted by
the International Health Conference, New York, 19-22 June, 1946; signed on 22 July 1946 by
the representatives of 61 States (Official Records of the World Health Organization, no.
2, p. 100) and entered into force on 7 April 1948.,http://www.who.int/about/definition/en/.
WHO (2001). The World Health Report 2001: Mental Health: New Understanding, New Hope,
World Health Organization.
WHO (2004). Revised GBD 2002 Estimates by WHO Sub-Region.
http://www3.who.int/whosis/menu.cfm?path=evidence,burden,burden_estimates,burden_est
imates_2002N,burden_estimates_2002N_2002Rev&language=english.
84
Williams, A. (1999). "Calculating the global burden of disease: time for a strategic
reappraisal?" Health Econ 8(1): 1-8.
Williams, A. (2000). "Comments on the response by Murray and Lopez." Health Econ 9(1):
83-6.
Wittchen, H. U., G. Lachner, et al. (1998). "Test-retest reliability of the computerized
DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI)." Soc
Psychiatry Psychiatr Epidemiol 33(11): 568-78.
Wittchen, H. U. and H. Pfister (1997). DIA-X-Interviews: Manual fur screening-verfahren
und Interview; Interviewheft Längsschnittuntersuchung (DIA-X-Lifetime); Ergänzungsheft
(DIAX-Lifetime); Interviewheft Querschnittuntersuchung (DIA-X-12 Monate); Ergänzungsheft
(DIA-X-12 Monate); PC-Programm zur Durchführung des Interviews (Längs- und
Querschnittuntersuchung). Frankfurt, Germany, Swets and Zeitlinger.
Wooldridge, J. M. (2002). Corner Solution Outcomes and Censored Regression Models.
Econometric Analysis of Cross Section and Panel Data. Cambridge, Massachusetts, The MIT
Press: 517-549.
Yonkers, K. A., S. E. Bruce, et al. (2003). "Chronicity, relapse, and illness-course of
panic disorder, social phobia, and generalized anxiety disorder: findings in men and women
from 8 years of follow-up." Depress Anxiety 17(3): 173-9.
